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Summary 
 
Splicing is a fundamental step in eukaryotic gene expression. During this process, 
introns are excised from pre-mRNAs and exons are ligated to form a continuous 
reading frame. As a consequence of splicing, a number of proteins are deposited on the 
mRNA product. These proteins can influence a number of downstream processes of the 
mRNA metabolism, such as export from the nucleus, translation efficiency and stability 
in the cytoplasm. It becomes evident that splicing not only plays an important role in 
the maturation of an mRNA in the nucleus, but also influences distant downstream 
processes affecting the ultimate fate of mRNAs. 
The exon junction complex (EJC) is assembled ~20-24 nucleotides upstream of 
splice junctions in a splicing-dependent, but sequence-independent manner (Le Hir et 
al., 2000). Trying to elucidate what influences the composition of the EJC, our 
hypothesis was that the intron downstream of the assembled EJC could influence its 
composition. It has been reported that NMD-competent mRNPs can be generated by 
distinct routes (Gehring et al., 2005). The question we wanted to address was whether 
this heterogeneity of NMD-activating complexes is reflected into EJC assemblies. In 
order to address this question we wanted to affinity select mRNPs spliced in vitro. We 
spliced NMD substrates in vitro and established a GRNA affinity purification method. 
The protein composition of the affinity purified mRNPs could not be studied with mass 
spectrometry, possibly due to the low amount of proteins. Immunoblot analysis 
revealed the presence of eIF4A3 and UAP56 within the affinity selected mRNPs. 
EJC has been assembled in vitro from recombinant proteins on a RNA substrate 
in the presence of ATP (Ballut et al., 2005). Therefore, its assembly can occur in the 
absence of the physiological deposition machinery, the spliceosome. However, under 
these experimental conditions, its physiological assembly hierarchy was not 
determined. One of the goals of this thesis was to study EJC deposition during splicing. 
The stepwise assembly of EJC during splicing, in parallel to the spliceosome assembly 
was investigated. We used an in vitro splicing system that faithfully recapitulates the 
splicing-dependent deposition of EJC proteins. We found that eIF4A3 and MAGOH-
Y14 formed a pre-EJC before exon ligation and that deposition of eIF4A3, MAGOH 
and Y14 required splicing, while Barentsz and UPF3b did not require splicing to bind at 
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the EJC. These results show that the minimal EJC (eIF4A3 and MAGOH-Y14) 
assembles on mRNA prior to exon ligation, while Barentsz and UPF3b join the 
complex later, after the completion of splicing to form an NMD-competent core EJC.  
While studying the splicing-mediated deposition of EJCs, we noticed that 
MAGOH mutants lacking the interaction with PYM subtly but reproducibly co-
immunoprecipitated more spliced MINX mRNA than wild type MAGOH. Therefore, 
we hypothesized that EJCs containing such mutants are more stable than EJCs with 
wild type MAGOH. To directly test if PYM influences the EJC, we purified 
recombinant PYM (rPYM) from bacterial expression cultures and added increasing 
amounts of rPYM to splicing reactions containing FLAG-tagged EJC proteins. The 
investigation led to the following observations: PYM reduced the amount of EJCs 
bound to spliced mRNAs and that the N-terminus of PYM was required for EJC 
disassembly. In addition, it was shown that PYM dissociated assembled EJCs but did 
not inhibit EJC assembly. These results reveal that PYM is an EJC disassembly factor 
in vitro that antagonizes important EJC functions. 
A number of protein complexes assemble on the mRNA in the nucleus, such as 
EJC and TREX. Evidence exists in the literature that EJC and TREX are connected. 
Some of the TREX complex components have been included into the EJC components 
(Gatfield et al., 2001; Le Hir et al., 2001b; Le Hir et al., 2000). It has yet to be 
demonstrated whether TREX complex deposition is EJC-dependent. We investigated 
the TREX complex deposition using the in vitro splicing system described before. The 
role of DDX39, a UAP56 paralogue protein, was addressed for the first time and 
compared to UAP56. The results revealed that TREX deposition was splicing-
independent and in particular that the recruitment of UAP56 and DDX39 was EJC-
independent, while ALY/REF interacted with the EJC. In addition, functional 
characterization of ALY/REF and UAP56 revealed that the ALY/REF residues 204-241 
were required for binding to the cap fragment, but not to the EJC fragment and that 
UAP56 mutants did not precipitate unspliced pre-mRNA or spliced mRNA fragments. 
The splicing-independent TREX complex deposition suggests that splicing is not 
necessary for export, but it may enhance export of spliced mRNAs. 
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Zusammenfassung 
 
Das Spleißen ist einer der grundlegenden Schritte der Genexpression in Eukaryonten. 
Durch den Spleißprozess werden Introns aus der pre-mRNA ausgeschnitten und die 
Exons zu einem durchgängigen offenen Leserahmen verknüpft. Als Folge des 
Spleißprozesses binden eine Reihe von Proteinen an die gespleißte mRNA. Diese 
Proteine beeinflussen andere Schritte des mRNA Stoffwechsels, z. B. den Export der 
mRNA aus dem Zellkern und die Effizienz der Translation und Stabilität im 
Zytoplasma. Das Spleißen spielt also nicht nur eine wichtige Rolle bei der Reifung von 
mRNAs im Zellkern, sondern bestimmt bei späteren Prozessen die endgültige 
Bestimmung von mRNAs. 
Der Exon Junction Complex (EJC) bindet an einer Position 20-24 Nukleotide 
vor Spleißverbindungen an die mRNA. Diese Bindung erfolgt spleißabhängig, ist 
jedoch vollkommen sequenzunabhängig (Le Hir et al., 2000). Wir wollten untersuchen, 
ob die Zusammensetzung von EJCs durch das von der Bindungsstelle stromab gelegene 
Intron beeinflusst werden kann. Frühere Arbeiten legten nahe, dass NMD kompetente 
mRNP Komplexe auf verschiedenen Wegen generiert werden können (Gehring et al., 
2005). Ob die unterschiedlichen NMD kompetenten Komplexe mit unterschiedlich 
zusammengesetzten EJCs korrelieren war eines der zentralen Fragen unserer 
Untersuchungen. Hierfür etablierten wir die Affinitätsaufreinigung von mRNPs, die 
mittels Spleißen in vitro generiert wurden. Solche in vitro mRNPs wurden mittels 
GRNA Chromatographie aufgereinigt. Die Zusammensetzung der Proteine in den 
isolierten mRNPs konnte aber nicht mit Massenspektrometrie aufklärt werden, da die 
benötigte Menge an Protein nicht erreicht wurde. In Immunoblots konnten jedoch in 
den aufgereinigten mRNPs die Proteine eIF4A3 und UAP56 nachgewiesen werden. 
Der EJC kann in vitro aus seinen vier rekombinanten Proteinkomponenten in 
Anwesenheit von ATP auf einem RNA Substrat zusammengesetzt werden (Ballut et al., 
2005). Dies bedeutet, dass er auch in Abwesenheit der physiologischen 
Spleißmaschinerie assemblieren kann. Der normale Ablauf des Zusammenbaus von 
EJCs konnte unter diesen Bedingungen aber nicht untersucht werden. Eines der Ziele 
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dieser Doktorarbeit war die Untersuchung des EJC Zusammenbaus während des 
Spleißvorganges. Hierzu wurde der schrittweise Aufbau des EJC parallel zum 
Spleißvorgang untersucht. Mit Hilfe eines experimentellen Systems, das die 
spleißabhängige Assemblierung von EJC-Proteinen darstellen kann, fanden wir, dass 
eIF4A3 und MAGOH-Y14 bereits vor der Exon-Ligation einen pre-EJC bilden. 
Obwohl eIF4A3 und MAGOH-Y14 während des Spleißens zusammengesetzt werden, 
binden Barentsz und UPF3b später an den bereits assemblierten pre-EJC. Dies bedeutet, 
dass erst durch die Bindung von Barentsz und UPF3b nach dem Spleißen ein NMD-
kompetenter EJC Kernkomplex gebildet wird. 
Während unserer Untersuchungen zur spleißabhängigen Assemblierung des EJC 
beobachteten wir, dass MAGOH Mutanten, die nicht mehr mit dem Protein PYM 
interagieren konnten, reproduzierbar mehr gespleißte mRNA immunpräzipitierten als 
der MAGOH Wildtyp. Wir stellten daher die Hypothese auf, dass EJCs, die diese 
Mutanten enthalten, stabiler sind als EJCs mit dem MAGOH Wildtyp. Um 
herauszufinden, ob PYM die Stabilität des EJC direkt beeinflussen kann, haben wir 
rekombinantes PYM (rPYM) bakteriell produziert und rPYM in Spleißreaktionen 
eingesetzt. Wir konnten zeigen, dass PYM die Menge von RNA-gebundenen EJCs 
verringert, und dass der N-Terminus von PYM für dieses Auseinanderbauen von EJCs 
benötigt wird. Wir fanden ausserdem, dass PYM zwar reife EJCs dissoziieren kann, 
nicht jedoch die Assemblierung des EJC während des Spleißens behindert. PYM ist 
also ein Faktor, der EJCs in vitro disassemblieren kann und der deshalb wichtigen 
Funktionen des EJC entgegenwirken kann.  
Eine Reihe von Proteinkomplexen bindet im Zellkern an die mRNA, z.B. der 
EJC oder der TREX-Komplex. Frühere Arbeiten konnten eine Verbindung zwischen 
dem EJC und dem TREX Komplex nachweisen. Einige der TREX Komponenten 
wurden ursprünglich als EJC Proteine angesehen (Gatfield et al., 2001; Le Hir et al., 
2001b; Le Hir et al., 2000). Dennoch wurde bislang noch nicht gezeigt, ob die 
Rekrutierung des TREX Komplex in Abhängigkeit des EJC erfolgt. Wir haben die 
Bindung des TREX Komplexes an mRNA mit unserem in vitro Spleißsystem 
untersucht. Die Funktion des Proteins DDX39, ein Homolog von UAP56, wurde dabei 
ebenfalls analysiert und mit UAP56 verglichen. Unsere Arbeiten konnten zeigen, dass 
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die Rekrutierung von UAP56 und DDX39 unabhängig vom EJC erfolgte, wohingegen 
ALY/REF mit dem EJC interagierte. Funktionelle Analysen zeigten, dass die 
Aminosäuren 204-241 von ALY/REF für die Bindung der mRNA Kappe benötigt 
wurden, jedoch nicht für die Interaktion mit dem EJC. UAP56 Mutanten banden weder 
an gespleißte, noch an ungespleißte RNAs. Die spleißunabhängige Bindung des TREX 
Komplex könnte darauf hindeuten, dass der Spleißvorgang nicht notwendig für den 
mRNA Export ist, diesen jedoch stimulieren kann.  
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1. INTRODUCTION 
 
The process of eukaryotic gene expression involves a number of interconnected steps 
with messenger RNA (mRNA) being the key intermediate in this process. During gene 
expression, the nascent mRNA transcripts are subjected to a number of processes in the 
nucleus, including capping at the 5’end, splicing to remove introns, and 
polyadenylation at the 3’end, before they are exported to the cytoplasm to be translated. 
A number of quality control mechanisms, such as nonsense-mediated decay (NMD), 
have evolved to recognize mistakes that occur during molecular processes in gene 
expression and to prevent the production of faulty gene products. Distinct multi-
component complexes carry out each of the above mentioned steps. Most of the 
processes and the complexes are physically and functionally coupled to one another. 
The mRNA does not travel alone throughout the cell; it is associated with proteins 
forming mRNPs (messenger ribonucleoprotein complexes). 
A very important feature of eukaryotic genes is the intron and a central process 
in the eukaryotic cells is splicing. Splicing removes the intervening sequences of the 
genes and unites the coding regions. It is carried out by a multi-component protein 
complex, the spliceosome. During splicing in the nucleus of metazoan cells, the 
spliceosome deposits the exon junction complex (EJC) on the nascent mRNA. The EJC 
modulates important nuclear and cytoplasmic events in gene expression such as nuclear 
export, nonsense-mediated mRNA decay, polysome association and translation. 
Components of the EJC are also involved in the localization of specific transcripts 
during development.  
A large number of different proteins bind to mRNA as it progresses to form a 
mature mRNP in the nucleus. Many of these proteins are associated with certain steps 
of the gene-expression pathway, such as transcription, splicing or polyadenylation, and 
are generally removed before nuclear export. Apart from those, many proteins remain 
bound to the mRNA and accompany mRNPs to the cytoplasm. A very appropriate 
example is the exon junction complex (EJC). Its components are thought to recruit the 
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member of another protein complex, the TREX complex (TRanscription EXport 
complex). 
1.1 The steps of gene expression 
 
In eukaryotic cells, the expression of most genes is a multi-step process that starts with 
the activation of transcription of the respective gene by RNA polymerases, leads to the 
production of proteins and ceases with the degradation of the products. At an activated 
locus, the RNA polymerase II transcription machinery copies the genetic information 
into the pre-mRNA. Eukaryotic RNAs undergo significant co- and post-transcriptional 
modifications. The 5’ ends of eukaryotic pre-mRNAs are modified co-transcriptionally 
by the addition of a protective m7GpppN cap structure that is also required for 
transcriptional elongation, splicing and mRNA export. The 3’end of an mRNA is 
cleaved and the poly(A)-tail is added (for a review, see (Shatkin et al., 2000)). A typical 
mRNA is shown in figure 1 and the different steps of gene expression are depicted 
schematically in figure 2. Genes in eukaryotes often contain introns (intervening 
sequences) that must be removed during gene expression. This process is known as 
splicing and represents one of the major steps in the control of eukaryotic gene 
expression (Jurica et al., 2003). Splicing will be described in detail in the next section. 
The regulated mechanism of splicing and splice site recognition can result in alternative 
splicing, allowing multiple different proteins to be translated from a single RNA 
transcript and hence is a means to modulate the final outcome of gene expression 
(Smith et al., 1989). Since these processes are tightly coupled and utilize common 
factors, transcripts that have failed to progress through a maturation step access more 
downstream processes less efficiently. Therefore, pre-mRNAs that are not efficiently 
processed may be retained in the nucleus and degraded by the nuclear exosome 
(Hilleren et al., 1999). After their proper processing, however, mRNAs are exported via 
the nuclear pore from the nucleus to the cytoplasm of the eukaryotic cell (for a review, 
see (Conti et al., 2001)). In the cytoplasm, translation, the deciphering of the mRNA  
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into a polypeptide, takes place. The multi-step process of translation is subdivided into 
the main steps of initiation, elongation and termination and is catalyzed by the 
ribosome. Each of these phases requires a distinct subset of protein factors that function 
in conjunction with the ribosome such as initiation factors, elongation factors and 
release factors. Once the mRNA has completed its function or if it is defective, it will 
be degraded by various RNA degradation processes after a characteristic time unique to 
each mRNA (Jacobson et al., 1996). In principle, the mRNA levels in a cell are 
influenced both by the rate of transcription and the rate of mRNA turnover (Jacob et al., 
1961). Bulk mRNA turnover can be considered as the key mechanism controlling the 
expression of many genes (Wilusz et al., 2004). 
 
 
 
 
Figure 1. Schematic representation of an mRNA. A typical mRNA consists of a 5’and 
3’untranslated region (UTR) and open reading frame (ORF). The 5’end has a protective 
methylated cap (m7GpppG) and the 3’end a poly(A)-tail. The codon AUG is the initiation 
codon and codons UAA, UAG and UGA are termination codons. 
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Figure 2. Simplified scheme of eukaryotic gene expression. The figure shows the different 
steps of gene expression, from transcription and nuclear mRNP processing steps (such as 5’end 
capping, splicing, mRNP assembly, 3’- end processing) to mRNP surveillance and RNA export. 
All these steps are coupled with or coordinated by transcription. EJC-exon junction complex; 
NMD-nonsense-mediated decay. 
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1.2 Splicing: at the center of gene expression 
 
In most of the eukaryotic genes the coding sequences (exons) are interrupted by 
intervening regions (introns). During splicing, the introns are removed and the exons 
are joined together, to generate a functional mRNA. Splicing consists of two 
subsequent transesterification reactions. During the first reaction, the 2’-hydroxyl of a 
conserved adenosine residue (the adenosine in the branch site) carries out a nucleophilic 
attack on the upstream boundary of the intron (the 5’splice site). The outcome of this 
reaction is the release of the upstream exon and the formation of a lariat intron. The 3’-
hydroxyl group of the newly released exon performs a second nucleophilic attack on 
the downstream boundary of the intron (the 3’splice site). This reaction results in the 
release of the lariat intron and the ligation of the two exons. The biochemical steps are 
depicted schematically in figure 3.  
 
 
Figure 3. Diagram illustrating the two biochemical steps of splicing. The grey cloud 
represents the spliceosome. The coloured shapes on the spliced mRNA represent the proteins 
associated with the mRNA during splicing. 
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Splicing is carried out by a sophisticated machinery, the spliceosome. It is 
composed of RNAs and proteins, more specifically by five spliceosomal small nuclear 
ribonucleoprotein complexes (U1, U2, U4, U5 and U6 snRNPs) termed UsnRNPs 
(uridine-rich small ribonuclear particles) and numerous non-small ribonucleoproteins 
(non-snRNPs). Each UsnRNP consists of an UsnRNA associated with a set of seven 
Sm or Sm-like proteins and several particle-specific factors. U1, U2, U4, U5 and U6 are 
the major UsnRNPs and they are responsible for splicing the majority of introns (U2-
type introns). U11, U12, U4atac and U6atac are less abundant snRNPs that are 
responsible for splicing, together with U5, of a less common class of introns, called 
U12-type introns.  
The spliceosome assembly begins with the interaction of U1 with the 5’splice 
site and U2 with the branch site, leading to complex A. Base-paired U4 and U6 bind U5 
form a tri-snRNP that joins complex A to give complex B. Structural changes that 
involve the dissociation of the intermolecular U4-U6 RNA base-pairing and the 
formation of interactions among U6, U2 and the pre-mRNA, catalytically activate the 
spliceosome. Complex B undergoes the first splicing reaction generating complex C. 
Subsequently, complex C undergoes the second catalytic step. After the second step, 
the complex is disassembled and the mRNA product is released. Figure 4 outlines the 
splicing assembly. 
Constitutive splicing takes place at strong splice sites and in the absence of 
repression factors. When these strong optimal splice sites are suppressed, alternative 
suboptimal sites are used and this process is called alternative splicing. Most 
alternatively spliced introns are controlled by several splicing enhancers and silencers. 
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Figure 4. Spliceosome Assembly. (A) The sequence features of metazoan pre-mRNAs are 
depicted schematically. The exons are depicted in a box shape and the intron as a line. In the 
scheme, the consensus sequences [5’splice site (SS), branch point sequence (BPS) and the 
3’splice site (SS)] are also indicated. In addition, another sequence, the polypyrimidine tract, 
which is located between the BPS and 3’SS, is shown. N stands for any nucleotide, R for a 
purine and Y for a pyrimidine. (B) Assembly and disassembly of the major spliceosome. The 
spliceosomal snRNPS are depicted in coloured circles.  
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1.2.1 Exon Junction Complex (EJC) 
 
The Exon Junction Complex is a multiprotein complex that is assembled ~20-24 
nucleotides upstream of splice junctions in a splicing-dependent manner (Le Hir et al., 
2001b), but sequence-independent. Since its discovery in 2000, a number of proteins 
have been named as EJC components.  
The composition of the EJC is thought to evolve as the mRNA travels from the 
nucleus to the cytoplasm (Degot et al., 2004; Kataoka et al., 2001; Kim et al., 2001b; Le 
Hir et al., 2001a; Le Hir et al., 2001b). The EJC components could be divided into the 
core components that remain bound to mRNAs in the nucleus and in the cytoplasm and 
a group of more transiently associated proteins that associate with the mRNAs at 
different steps. The core complex is comprised of MLN51 (Metastatic Lymph Node 51) 
or Barentsz, the heterodimer MAGOH:Y14 and eIF4A3 that constitutes a platform onto 
which the rest of the EJC is assembled (Ballut et al., 2005; Chan et al., 2004; Degot et 
al., 2004; Ferraiuolo et al., 2004; Kataoka et al., 2000; Le Hir et al., 2001a; Le Hir et 
al., 2001b; Palacios et al., 2004; Tange et al., 2005).  
The second set of factors, those that are transiently associated, includes 
SRm160, RNPS1, Acinus, SAP18 and Pinin (related to splicing), UAP56, ALY/REF 
and TAP-p15 (related to mRNA export) and the proteins UPF3 and UPF2 (NMD 
factors) (Le Hir et al., 2008a; Le Hir et al., 2008b; Tange et al., 2004). RNPS1 and 
UPF3 remain associated to the mRNA both in the nucleus and the cytoplasm. 
The EJC has been implicated in a number of nuclear and cytoplasmic processes. 
It increases the efficiency of mRNA export in Xenopus laevis oocytes (Le Hir et al., 
2001b) and enhances translation in both Xenopus oocytes and mammalian cells (Nott et 
al., 2004; Wiegand et al., 2003). In addition, several EJC protein components are 
required for the correct localization of oskar mRNA and antero-posterior axis formation 
during early embryonic development in Drosophila melanogaster (Hachet et al., 2001; 
Mohr et al., 2001; Palacios et al., 2004). All the accumulated evidence define EJC as a 
key regulator of mRNA function in higher eukaryotes (Le Hir et al., 2003; Tange et al., 
2004).  
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The EJC has been reconstituted in vitro from recombinant proteins (Ballut et al., 
2005). It was shown that the four proteins, MAGOH-Y14, eIF4A3 and the SELOR 
fragment of MLN51 (Barentsz) form a highly stable complex that requires the presence 
of RNA and ATP. 
The crystal structure of the EJC core shows the organization of the four proteins 
around the RNA (Figure 5) (Andersen et al., 2006; Bono et al., 2006). From this 
structure, important insights can be obtained on how the MAGOH-Y14 inhibits eIF4A3 
helicase activity thus locking the EJC on the RNA. Moreover, it becomes apparent that 
MLN51 stimulates the activity of eIF4A3. 
 
 
 
Figure 5. Crystal structure of the EJC. In this figure, the human EJC is shown in two 
orientations (the structure shown in (A) is rotated 180° around a vertical axis). The Barentsz 
protein (Btz; shown in red) stretches around the DEAD-box helicase eIF4A3 (in yellow). Both 
proteins interact with RNA (in black), which is bound at a cleft formed between the two RecA-
like domains of eIF4A3. ATP (in gray) binds at an interface between the two domains of 
eIF4A3, distinct from the RNA binding cleft. The other two protein components of the EJC, 
Mago (blue), and Y14 (magenta), bind mainly to domain 2 of eIF4A3, but the interaction 
surface also extends over to the interface with domain 1. The figure was taken from (Bono et 
al., 2006). All ribbon drawings were rendered using PyMOL (DeLano, W.L., 2002, 
http://www.pymol.org). 
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Trying to elucidate the hierarchy of the EJC assembly, the analysis of purified 
H, C, and mRNP complexes revealed that at least one EJC component, ALY/REF, can 
interact with pre-mRNA prior to spliceosome assembly. In mammals the H complex is 
nonspecific, assembles first, it does not require splice sites or ATP and consists of 
hnRNP proteins (Bennett et al., 1992; Konarska et al., 1986). On the other hand, Y14, 
MAGOH, RNPS1, UAP56, and SRm160 are found in intermediate-containing 
spliceosomes. The proteins ALY/REF, Y14 and MAGOH remain stably bound to 
spliced mRNA, while the association of RNPS1, UAP56, and SRm160 is destabilized 
at the step of exon ligation (Reichert et al., 2002). Kataoka and colleagues developed a 
simple whole cell lysate system for in vitro splicing, to study the EJC assembly during 
splicing. Three of the EJC components, ALY/REF, RNPS1 and SRm160, are found on 
pre-mRNA by the time the spliceosome is formed, whereas Upf3b associates with 
splicing intermediates during or immediately after the first catalytic step of the splicing 
reaction (cleavage of exon 1 and intron-lariat formation). In contrast, Y14 and 
MAGOH, which remain stably associated with mRNA after export to the cytoplasm, 
join the EJC during or after completion of exon-exon ligation. These findings give the 
first hint that EJC formation is an ordered pathway, that involves a stepwise association 
of components and is coupled to specific intermediates of the splicing reaction 
(Kataoka et al., 2004). The exact assembly pathway of the core EJC, during the two 
distinct reactions involved in splicing, remains to be clarified. 
A number of questions about the EJC is still unanswered. One of the most 
interesting questions is when/how the EJC is removed from the mRNA and what is the 
destiny of the stripped-off mRNA factors, possibly recycled to be used at the next 
cycle. It has been shown that at least Y14 remains associated with mRNAs in the 
cytoplasm until they are translated. According to the current model in literature, 
translation is responsible for the removal of Y14 from mRNAs, and thus of the EJC 
(Dostie et al., 2002). 
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1.3 mRNA nuclear export 
 
In eukaryotic cells, the processes of the nucleus are separated from those in the 
cytoplasm by a double membrane, the nuclear envelope. The transport between the 
nucleus and the cytoplasm is mediated by receptors that recognize specific cargoes and 
carry them through the nuclear pore complex (NPC). All known receptors are members 
of the karyopherin/importin-β family of proteins that function by interacting with the 
small GTPase Ran (Mattaj et al., 1998). The karyopherin/importin-β family members 
and Ran do not seem to be involved in the export of spliced mRNA. mRNA export is 
employing the TAP/p15 heterodimer (Mex:Mtr2 in yeast) (Braun et al., 2001; Guzik et 
al., 2001; Katahira et al., 1999). 
Nuclear export of mRNA is tightly associated with the controlled remodelling 
of mRNP complexes (Cole et al., 2006a, b). A great number of different proteins bind 
to mRNA as it progresses to form a mature mRNP in the nucleus. Many of these 
proteins are associated with certain steps of the gene-expression pathway, such as 
transcription, splicing or polyadenylation, and are generally removed before nuclear 
export. Apart from those, many proteins remain bound to the mRNA and accompany 
mRNPs to the cytoplasm, although not all are involved directly in nuclear export, such 
as the exon junction complex (EJC). The precise way in which completion of mRNP 
maturation is recognized is still unclear. Binding of Mex67:Mtr2 is necessary for export 
(Braun et al., 2001; Guzik et al., 2001; Katahira et al., 1999). Apart from Mex67, which 
has an mRNA-binding domain, adaptor proteins such as REF/Aly/Sub2, EJC 
components and SR (Serine/Arg rich) proteins, also promote its binding to mRNPs 
(Huang et al., 2005; Moore, 2005) . 
Translocation of mRNP complexes is thought to be mediated primarily by weak 
interactions between the TAP/p15 heterodimer and the FG-nucleoporins, NPC proteins 
that harbour Phe-Gly repeats. Transport complexes generally move through the NPC by 
simple diffusion. The function of the carrier is to facilitate equilibrium of the transport 
complex between the inner and the outer compartments by a passive mechanism that 
prevents the return to the donor compartment (Cole et al., 2006a). The mechanism by 
which TAP/p15 is removed from the mRNP is still unclear. In budding yeast, it has 
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been observed that the DEAD-box helicase Dbp5 remodels mRNPs at the cytoplasmic 
NPC side by removing Mex67 (the yeast homologue of TAP). Its ATPase activity is 
activated by Gle1, an essential mRNA export factor and an inositol hexaphosphate (IP6) 
(Alcazar-Roman et al., 2006; Weirich et al., 2006). 
 
1.3.1 Human TREX (TRanscription-EXport) Complex 
 
TREX is a protein complex conserved from yeast to metazoans (Gatfield et al., 2001; 
Jensen et al., 2001; Luo et al., 2001; Strasser et al., 2000, 2001; Stutz et al., 2000; Zhou 
et al., 2000). This conserved complex provides one of the best examples of coupling 
different mechanisms in yeast versus metazoans, as it is associated with the 
transcription machinery in yeast and the splicing machinery in humans (Reed et al., 
2005). 
The human TREX complex contains the proteins UAP56 and ALY/REF (known 
as Sub2 and Yra1 in yeast) as well as the multisubunit THO complex (Jimeno et al., 
2002; Masuda et al., 2005; Strasser et al., 2002). The human THO complex is 
comprised of hTho2, hHpr 1, f SAP79, f SAP35 and f SAP24. The components of the 
TREX complex in yeast, Drosophila melanogaster and mammals are shown in detail in 
table 1. In yeast, Sub2 and Yra1 are co-transcriptionally recruited to nascent transcripts 
by the THO complex (Abruzzi et al., 2004). In contrast, the human TREX complex has 
been suggested to be loaded onto mRNA during splicing (Masuda et al., 2005). RNA 
interference and biochemical studies in metazoans and genetic analyses in yeast 
indicate that the conserved TREX complex functions in mRNA export (Gatfield et al., 
2003). 
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Figure 6. Splicing-coupled mRNA export in metazoans. For metazoan, several mRNA 
export models have been described. In this figure, the splicing- and cap-dependent modes of 
human TREX recruitment to the mRNP are depicted. Export receptors are indicated in pink and 
adaptors in grey.  
 
The deposition of the human TREX complex has been addressed in a number of 
studies. In previous work, UAP56 and ALY/REF were identified as components of the 
exon junction complex (EJC) (Gatfield et al., 2001; Le Hir et al., 2001b; Le Hir et al., 
2000). The EJC was also reported to contain the mRNA export receptor TAP/p15 (Le 
Hir et al., 2001b; Tange et al., 2004).  
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Masuda and coworkers identified the human THO complex and showed that it is 
associated with spliced mRNA, but not with unspliced pre-mRNA in vitro. The human 
THO complex co-localizes with splicing factors in nuclear speckle domains in vivo. 
Considering that splicing occurs co-transcriptionally in humans, their data indicate that 
recruitment of the human TREX complex to spliced mRNA is not directly coupled to 
transcription, but is instead coupled to transcription indirectly through splicing. 
Studying the requirement of the ALY/REF-UAP56 interaction, they found that 
ALY/REF interacts with UAP56-C terminus as efficiently as with full-length UAP56, 
indicating that the C terminus is sufficient for ALY/REF binding. Both UAP56 and the 
hTHO complex bind at the C terminus of ALY/REF (Masuda et al., 2005). 
In a more recent study, Cheng and co-workers sought to determine whether the 
human THO complex is also deposited on the mRNA as part of the EJC. This analysis 
revealed that the human TREX complex is recruited in a splicing- and cap-dependent 
manner to a region near the 5’end of the mRNA. Their data indicate that ALY/REF 
binds to the mRNA closest to the cap and THO complex, while UAP56 binds 
downstream of ALY/REF but upstream of the EJC. In their model, the recruitment of 
the TREX complex to mRNA occurs via an interaction between the TREX component-
ALY/REF and the cap-binding protein CBP80. While the TREX complex is bound only 
on the first exon, the EJC is recruited at every exon-exon junction independently of the 
5’ cap/CBP80. In addition, the above paper suggests that the cap has a role in mRNA 
export only for spliced mRNAs and not for cDNA transcripts or random RNAs (Cheng 
et al., 2006). Moreover, analysis of ALY/REF mutants identified a mutant that lacks 16 
C-terminal amino acids, totally disrupting the binding to UAP56. This mutant still 
binds to CBP80. The recruitment of TREX at the 5′end of mRNA provides a 
biochemical explanation for electron microscopic studies showing that the mRNPs of 
the giant Balbiani rings of Chironomus tentans translocate through the nuclear pore in a 
5′ to 3′ direction (Daneholt, 1997; Mehlin et al., 1992; Visa et al., 1996a). CBC is 
detected on the 5′end of the Balbiani ring mRNP and is co-exported with it to the 
cytoplasm (Visa et al., 1996a; Visa et al., 1996b). The Balbiani ring data also indicate 
that the ribosome associates with the mRNA as it emerges from the nuclear pore 
(Daneholt, 1997; Mehlin et al., 1992; Visa et al., 1996a). It is already known that 
INTRODUCTION 
 
 
15 
 
cap/CBC is present on unspliced pre-mRNA (Visa et al., 1996b), yet TREX is not 
recruited to unspliced pre-mRNA. The cap/CBC is also present on cDNA transcripts, 
yet TREX is not efficiently recruited to them either. Interesting questions that remain to 
be answered are whether the cap plays a role in export of naturally intronless mRNAs 
and whether TREX is recruited to the 5′end. It is thus interesting to investigate the 
contribution of the EJC to the deposition of TREX complex.  
 
Yeast TREX 
Complex 
Drosophila TREX 
Complex 
Human TREX 
Complex 
Sub 2 UAP56 UAP56 
Yra 1 REF ALY/REF 
Tex1 TEX1 hTex1 
Yeast THO 
Complex: 
Drosophila THO 
Complex: 
Human THO 
Complex: 
Mft1 - - 
Thp2 - - 
Tho2 THO2 hTho2 
Hpr1 HPR1 hHpr1 
- THOC5 f SAP79 
- THOC6 f SAP35 
- THOC7 f SAP24 
 
Table 1: Members of the conserved TREX complex in yeast, Drosophila melanogaster and 
human are listed. 
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1.4 mRNA first round of translation: decision to translate or to 
degrade 
 
In the nucleus of mammalian cells, the mRNA 5’cap is recognized by the cap binding 
complex, which is a heterodimer consisting of a small (CBP20) and a big (CBP80) 
subunit (Mazza et al., 2001). The 3’poly-A tail is associated to the nuclear poly-A-
binding protein (PABPN1). Once the mRNA is exported to the cytoplasm, CBC 
interacts with translation initiation factor 4G (eIF4G), which is required for the 
recruitment of the small ribosomal subunit. When the small ribosomal subunit is 
recruited, it initiates the 5’ to 3’scanning of the 5’UTR, searching for an AUG start 
codon (Lejeune et al., 2004). Once the start codon is identified, the large ribosomal 
subunit is recruited and the 80S translation-competent complex is formed. During 
translation, a number of nuclear-acquired factors associate at the mRNA ORF (open 
reading frame) are dissociated. In addition to the remodeling, premature translation 
termination codons (PTCs) are recognized. Once a termination codon is found, the 
presence of an EJC downstream is assessed. If both, a termination codon and an EJC 
are present, the mRNA is degraded by a mechanism called nonsense-mediated mRNA 
decay (NMD). 
Contrary to the first round of translation, steady-state translation carries out the 
bulk of cellular protein synthesis. The mRNAs do not carry EJCs at their exon-exon 
junctions, CBC is replaced with the major cytoplasmic cap-binding protein eIF4E and 
PABPN1 is replaced by the cytoplasmic poly-A-binding protein PABP. 
 
1.5 mRNA quality control and nonsense-mediated mRNA decay 
 
Mutations in a transcript can lead to severe consequences in the regulatory network of 
mRNA metabolism. Eukaryotic cells have developed a number of quality control 
mechanisms that recognize defective mRNAs and eliminate them. The crucial role of 
these surveillance mechanisms is underlined by the finding that several human diseases 
are linked to defective mRNA metabolism (Hentze et al., 1999). 
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1.5.1 Nonsense-mediated mRNA decay limits the expression of 
truncated polypeptides 
 
Nonsense-mediated mRNA decay (NMD) is an RNA surveillance pathway that 
recognizes and degrades mRNAs carrying a premature translation termination codon 
(PTCs). In order for a termination codon to be perceived as premature, it has to occur 
>50-55 nucleotides upstream of the last exon-exon boundary (Figure 7). In mammalian 
cells, NMD is linked to splicing. For the activation of NMD in mammals two signals 
are required. The first signal is the existence of a PTC. The physiological termination 
codon and the PTC have the same sequence; therefore a way needs to be found to 
distinguish the two types of stop codons. Once a termination codon is recognized, the 
current hypothesis states, that the ribosome scans the mRNA in order to find the exon 
junction complex (EJC) at a downstream exon-exon junction. If the EJC is present, 
NMD is activated and the mRNA is degraded (Figure 8). 
 
 
 
 
Figure 7. PTC definition in mammals. The figure depicts a mRNA with three exons. 
According to this “50-55 nt rule”, a stop codon located in the green region would trigger NMD, 
while a stop codon situated in the red region would be considered physiological and would not 
trigger NMD. 
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Figure 8. Model illustrating mammalian NMD. Splicing in the nucleus deposits a protein 
complex 20 to 24 nts upstream of each exon-exon junction, the exon junction complex 
(depicted with the orange oval shape). The exon junction complex is thought to recruit further 
NMD factors. Upon transport through the nuclear pore, the EJC is remodeled and several 
factors are released. During the first round of translation, EJCs are removed by the elongating 
ribosome. If the translating ribosome encounters a PTC (premature termination codon) at least 
50-55 nts upstream of an exon-exon junction, NMD is triggered. Otherwise, the ribosome 
removes the termination codons and NMD is not activated. 
AIMS OF THE STUDY 
 
 
19 
 
1.6 Aims of the Study 
 
Profound knowledge of the molecular mechanisms of protein deposition on the RNA 
during splicing will improve our understanding of mRNP formation. In particular, the 
elucidation of the deposition of the EJC and TREX complex will help to establish the 
connection between splicing and downstream processing mechanisms of mature RNA 
in mammals. 
Although the EJC is central in the mechanism of mammalian NMD, little is 
known about the exact assembly line of it. Another important question is whether EJCs 
of differential composition exist.  
The aim of this thesis was to study the protein composition of the mRNPs 
focusing on the EJC and the TREX complexes. The first goal was to affinity purify 
different spliced mRNPs and investigate the composition of the EJC. To reach this goal, 
the GRNA affinity purification method was chosen as an experimental system. The aim 
was to affinity purify mRNPs of different substrates spliced in vitro. This approach will 
be used to compare the potential different EJC subcomplexes assembled on different 
introns, such as MINX and β-globin.  
The second goal was to study the assembly and disassembly of the EJC. The 
third goal was to investigate the deposition of TREX. Several models of mRNA export 
and TREX deposition exist in the literature. There are multiple suggestions of what 
dictates the TREX recruitment, for instance cap-dependency, splicing-dependency or 
EJC-dependency. I particularly wanted to test the contribution of splicing and the EJC 
to the recruitment of TREX factors.  
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2. MATERIALS AND METHODS 
 
2.1 Materials 
2.1.1 Chemicals 
 
All salts and standard chemicals were purchased from Roth (Karlsruhe, Germany) and 
Sigma-Aldrich (Taufkirchen, Germany). Cell culture media were purchased from Gibco 
BRL div. of Invitrogen (Karlsruhe, Germany). Exceptions to this statement are the 
following: 
 
Agarose Biozym Scientific (Oldendorf, Germany) 
Bacto-agar Becton, Dickinson and Co. (Sparks, USA) 
Bromophenolblue Serva (Heidelberg. Germany) 
CaCl2 (calcium chloride) ICN Biomedicals (Ohio, USA)) 
Complete EDTA-free protease inhibitor Roche (Mannheim, Germany) 
DTT (dithiothreitol) Promega (Madison, USA) 
Formaldehyde Merck (Darmstadt, Germany) 
NaAc (sodium acetate) Merck (Darmstadt, Germany) 
Nucleotides (NTPs) and deoxy-nucleotides 
(dNTPs) 
MBI Fermentas (Burlington, Canada) or 
Promega (Madison , USA) 
Trizol (TriReagent) MRC (Cincinnati, USA) 
Tris-base Merck (Darmstadt, Germany) 
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2.1.2 Enzymes 
 
Restriction enzymes were purchased from New England Biolabs (NEB) (Ipswich, MA, 
USA), together with the appropriate buffers. SP6, T7 and T3 RNA-polymerases were 
purchased from Roche (Mannheim, Germany). PCR reactions were performed with 
Phusion Polymerase (Finnzymes, Espoo, Finland) or Taq Polymerase (NEB). 
 
2.1.3 DNA oligonucleotides 
 
DNA oligonucleotides were ordered from Biomers (Ulm, Germany). PCR primers were 
obtained in desalted, lyophilized form, and were diluted in H2O. 
 
2.1.4 Antibodies 
 
The antibodies and corresponding dilutions that were used in this study are listed 
below. 
Antibody Properties Supplier Dilution 
αBARENTSZ Polyclonal, rabbit  Produced by us 1:1000 
αFLAG Polyclonal, rabbit  Sigma-Aldrich 1:2000 
αMAGOH Monoclonal, mouse  AbCam, UK 1:2000 
αeIF4A3 Polyclonal, rabbit  Produced by us 1:1000 
αRNPS1 Polyclonal, rabbit  Krainer laboratory 1:4000 
αUPF3b Polyclonal, rabbit  Lykke-Andersen 
laboratory 
1:5000 
αY14 Polyclonal, rabbit Izaurralde laboratory 1:1000 
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αUAP56 Polyclonal, rabbit AbCam, UK 1:2000 
αTHOC4 Polyclonal, mouse AbCam, UK 1:1000 
α mouse IgG 
peroxidase coupled 
Polyclonal, goat Sigma-Aldrich 1:5000 
α rabbit IgG 
peroxidase coupled 
Polyclonal, goat Sigma-Aldrich 1:5000 
  
2.1.5 Kits 
 
The following kits were used throughout the study. Unless stated otherwise, the 
manufacturer’s recommendations were followed. 
 
Application Name Supplier 
Plasmid DNA extraction 
from agarose gels, 
PCR reactions or enzymatic 
digests 
QIAquick™ Gel 
Extraction Kit 
Qiagen, Hilden, 
Germany 
DNA preparation from E. coli QIAprep™(mini, 
midi and maxi) Kit 
Qiagen 
In vitro synthesis of large 
amounts of capped RNA 
mMESSAGE 
mMACHINE® 
Ambion 
Silver Staining SilverQuest™ Silver 
Staining Kit 
Invitrogen 
Affinity Resin for antibodies AminoLink® Plus 
Immobilization Kit 
Thermo Scientific 
Pierce 
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2.1.6 Instrumental material 
 
Agarose gel electrophoresis equipment Peqlab Biotechnologie (Erlangen, Germany) 
Acrylamide gel (SDS-PAGE) electrophoresis 
equipment 
Whatman-Biometra (Goettingen, Germany) 
Acrylamide gel (with urea) electrophoresis 
equipment 
Owl Separation Systems (Portsmouth,USA) 
Blotting (Trans-Blot SD semi-dry transfer 
cell) 
Bio-Rad (Hercules, USA) 
Photometer (Biophotometer) Eppendorf (Hamburg, Germany) 
Ultrasonic processor Model VC130PB 
(Sonicator)  
Sonics & Materials Inc. (Newtown, USA) 
Thermocycler (T3000) Whatman-Biometra (Goettingen, Germany) 
PhospoImager FLA-3000 FujiFilm-LifeScience (Düsseldorf, Germany) 
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2.1.7 Commonly used buffers, solutions and media 
 
All solutions were prepared with double deionized water. 
 
Antibiotic solutions (1000x) 100 mg/ml ampicillin in H2O 
50 mg/ml kanamycin in H2O 
Anode buffer (Immunoblot) 25 mM Tris 
BBS (2x) for transfection 50 mM BES (N,N-bis(Hydroxyethyl)-2- 
Aminoethansulfonat) 
280 mM NaCl 
1.5 mM Na2HPO4 
pH 6.96 (adjusted with 10 N NaOH) 
filter sterilized (0.22 μm) 
CaCl2 for transfection 2.5 M CaCl2 
Cathode buffer (Immunoblot) 25 mM Tris-HCl 
40 mM 6-amino-4-hexanoic acid 
0.01% (w/v) SDS 
Coomassie stain solution: For 1 L: 40% (v/v) methanol 
10% (v/v) acetic acid 
2.5 g Coomassie Brilliant Blue (Sigma-Aldrich) 
 
Coomassie destain solution: 10% (v/v) methanol 
10% (v/v) ethanol 
DNA loading buffer (6x) 0.9% (w/v) bromophenol blue (Sigma-Aldrich) 
60% (v/v) glycerol 
60 mM EDTA pH 8.0 
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Glutathione Buffer (Elution buffer 
for GRNA Chromatography) 
50 mM L-Glutathione reduced minimum 99%  
500 mM Tris pH 8.0 
1 mM DTT 
IP buffer 1  
(GRNA Chromatography) 
500 mM NaCl 
20 mM Tris-HCl pH 7.5 
1.5 mM MgCl2 
0.05% (v/v) Nonidet® P40 (Igepal CA-630) 
8.7% (v/v) Glycerol 
12 μg/ml Heparin 
IP buffer 2  
(Flag Affinity Purification) 
150 mM NaCl  
20 mM HEPES pH 7.9 
0.1% (v/v) Nonidet® P40 (Igepal CA-630) 
1 mM MgCl2 
0.2% (v/v) Triton X 100 
0.05% (w/v) deoxycholate 
Luria-Bertani (LB) agar 
(autoclaved) 
15 g/l Bacto agar in LB medium 
LB medium (autoclaved) 10 g/l Bacto tryptone 
5 g/l Bacto yeast extract 
5 g/l NaCl 
pH 7.6 (adjusted with 5 N NaOH) 
Ponceau staining solution 0.5% (w/v) Ponceau S dye 
1% (v/v) acetic acid 
Resolving gel (8% to 12%) 
solution 
 
375 mM Tris-HCl, pH 8.8 
8 to 12 % (w/v) acrylamide/bisacrylamide 
0.1% (w/v) SDS 
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RNase A 3.5 mg/ml RNase A in RNase digestion buffer 
50% (v/v) glycerol 
RNA loading buffer for 
In vitro splicing assay 
80% formamide (Sigma-Aldrich) 
0.1% (w/v) xylene cyanol 
0.1% (w/v) bromophenol blue 
2 mM EDTA, pH 8.0 
SDS Sample Buffer (6x) 350 mM Tris-HCl, pH 6.8 
600 mM DTT 
30% (v/v) glycerol 
10% (w/v) SDS 
0.012% (w/v) bromophenol blue 
SDS Running Buffer (Laemmli 
buffer) (5x) 
1.5 % (w/v) Tris  
7.2% (w/v) Glycine 
0.5% (w/v) SDS 
Stacking gel (5%) solution 125 mM Tris-Cl, pH 6.8 
5 % (w/v) acrylamide/bisacrylamide 
0.1 % (w/v) SDS 
TBE (10x)  0.89 M Tris base, pH 8.3 
0.89 M boric acid 
20 mM EDTA, pH 8.0 
TBS 20 mM Tris-HCl, pH 7.6 
137.5 mM NaCl 
TBS-Tween 20 mM Tris-HCl pH 7.6 
137.5 mM NaCl 
0.05% (v/v) Tween 20 
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Total cell lysis buffer (for protein 
isolation) 
0.5 % Triton X-100 
1x Complete protease inhibitor (Roche) 
30 μg/μl RNase A 
In TBS 
TE buffer 10 mM Tris-Cl 
1 mM EDTA 
 pH 7.5 
 
2.1.8 HeLa Nuclear Extract 
 
The HeLa 5.0 x 109 nuclear extract used for the in vitro splicing reactions was 
purchased from CilBiotech (Mons, Belgium). 
 
2.1.9 Eukaryotic cell lines 
 
In the present study, two cell lines were used HeLa and HEK 293 cell lines. The HeLa 
cell line originates from a human cervical carcinoma. The HEK 293 cells were 
purchased from Invitrogen and their complete name is GripTite™ 293 MSR Cell Line. 
This cell line is a genetically engineered Human Embryonic Kidney (HEK 293) cell 
line that expresses the human macrophage scavenger receptor and strongly adheres to 
standard tissue culture plates for dependable results. Developed from a 293-H subclone, 
GripTite™ 293 MSR cells show the same fast cell growth, high transfection efficiency, 
and high-level expression characteristics of the parental 293-H cells. 
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2.1.10 Plasmids 
 
The following plasmids were used in the present thesis: pCI-neo (Promega), pGEM-4Z 
(Promega), pGEM7 (Promega) and pBlueskriptSK II+ (Stratagene) are the basic 
plasmids used to clone all the constructs used in the present study. Each construct was 
generated as shown in the table below. All PCR amplified inserts were validated by 
sequencing (GATC Biotech). 
 
Name Features 
pGEM4- MINX MINX (Bell et al., 2002) was cloned 
EcoRI/BamHI into pGEM4. 
pGEM4- MINX (15) Generated by PCR-mutagenesis. 
pGEM4- MINX Δintron Generated by PCR-mutagenesis. 
pGEM4- MINX GG Generated by PCR-mutagenesis. 
pGEM4- MINX GG (15) Generated by PCR-mutagenesis. 
pGEM4- MINX+30 Generated by PCR. The primer apart from the 
restriction enzyme site included a 30nts-
sequence of β-globin. 
pGEM4- MINX Δi+30 Generated by PCR. The primer apart from the 
restriction enzyme site included a 30nts-
sequence of β-globin. 
pGEM7- MINX MINX sequence was amplified from pGEM4-
MINX and cloned Sac I/Xma I. 
pGEM7- MINX-4BoxBs The BoxBs sequence was inserted Xma I/ 
Xho I to the above construct. 
pCI neo-Flag Created by inserting the Flag-sequence into 
the NheI/XhoI sites of pCI-neo vector 
(Gehring et al., 2003). 
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pCIneo-FlagY14 The sequence of Y14 was subcloned from a 
pCI-λN-Y14 construct into the XhoI site of 
pCIneo-Flag (Gehring et al., 2003).  
pCIneo-FlagRNPS1 RNPS1 sequence was amplified from HeLa 
cDNA and cloned like Y14 (Gehring et al., 
2003). 
pCIneo-FlageIF4A3 Gehring et al., 2009 
pCIneo-FlagMAGOH Gehring et al., 2009 
pCIneo-FlagBarentsz Gehring et al., 2009 
pCIneo-FlagCBP80 CBP80 sequence was amplified from HeLa 
cDNA and cloned into pCI-neo FLAG. 
pCIneo-FlagUAP56 Cloned by PCR amplification of the 
respective ORFs from HeLa cDNA and 
ligation to pCIneo-Flag construct. 
pCIneo-FlagUAP56 ΔC171 Generated by site directed PCR mutagenesis. 
pCIneo-FlagUAP56 ΔN251 Generated by site directed PCR mutagenesis. 
pCIneo-FlagUAP56K95N Generated by site directed PCR mutagenesis. 
pCIneo-FlagDDX39 Cloned by PCR amplification of the 
respective ORFs from HeLa cDNA and 
ligation to pCIneo-Flag construct. 
pCIneo-FlagALY/REF Cloned by PCR amplification of the 
respective ORFs from a plasmid obtained 
from Origene and ligation to pCIneo-Flag 
construct. 
pCIneo-FlagALY/REF ΔC53 Generated by site directed PCR mutagenesis. 
pCIneo-FlagALY/REF ΔC16 Generated by site directed PCR mutagenesis. 
pCIneo-FlagALY/REF ΔN80 Generated by site directed PCR mutagenesis. 
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2.1.11 Sequences of oligonucleotides used in PCR reactions 
 
DNA oligonucleotides were ordered from Biomers (Ulm, Germany). PCR primers were 
obtained in desalted, lyophilised form and were dissolved in water. In addition, those 
primers used to amplify pre-mRNA were HPLC-purified.  
 
Name Sequence Restriction Site 
Minx-Upstream  TTT TTC GAG CTC CCA CTC TTG GAT 
CGG AAA CCC GTC GGC CTC CGA 
ACG GT 
Sac I 
Minx-Downstream TTC CCC CGG GAG AGT TTG TCC 
TCA ACC GCG AGC TGT GGA AAA 
AAA A 
Xma I 
β-globin Upstream TTT TTC GAG CTC GCA AGG TGA 
ACG TGG ATG AAG TTG GTG GTG 
AGG CCC TG 
Sac I 
β-globin Downstream TTT TTC CCC CGG GCC TCT GGG TCC 
AAG GGT AGA CCA CCA GCA GCC T 
Xma I 
MS2Box Upstream  CCC CCC GGG GGG GTT CCC TAA 
GCT CGA CCA AAG G 
Xma I 
MS2Box Downstream CCC TCG AGG GAG TTT AGT ACT 
CGA GGT CGA GTG CA 
Xho I 
MINX+30 Upstream 
and 
MINX Δi+30 
Upstream 
TTTTGAATTCTGTGTTCACTAGCAAC
CTCAAACAGACACCGAGCTCGCCCA
CTCTT 
EcoRI 
MINX+30 
Downstream 
and 
MINX Δi+30 
Downstream 
TTTTGGATCCTAATACGACATCACTA
TAGGGC 
BamHI 
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2.2 Methods 
 
2.2.1 Bacterial Techniques 
 
2.2.1.1 Bacterial strains 
 
For the propagation of plasmid DNA, the E. coli strain XL1-Blue from Stratagene (La 
Jolla, CA, USA) was used. The genotype of this strain is the following: hsdR17, 
supE44, recA1, endA1, gyrA96, thi, relA1, lac/F´[proAB+ lacIa, 
lacZΔM15:Tn10(TetR)]. 
 
2.2.1.2 Preparation of transformation-competent E.coli 
 
For the preparation of transformation competent E.coli XL1-Blue, bacteria were 
streaked onto LB agar and incubated at 37°C over night. A single colony was 
inoculated into 5 ml LB medium and allowed to proliferate over night at 37°C. One 
milliliter of the bacterial suspension was transferred to 100 ml LB medium and 
incubated at 37°C until the suspension reached an OD600 of 0.6. The culture was 
cooled on ice, and the bacterial cells were pelleted by centrifugation at 1,200 g for 5 
minutes in a pre-cooled rotor. The bacterial pellet was resuspended in 10 ml of ice-cold 
TSS, aliquoted in pre-cooled reaction tubes and stored at -80°C. Aliquots were tested 
by transformation with serial dilutions of plasmid DNA for transformation efficiency of 
at least 106 colonies per μg of plasmid DNA. 
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2.2.1.3 Transformation of bacteria 
 
One hundred nanograms of plasmid DNA or 10 μl of ligation reaction were mixed with 
100 μl of transformation-competent E.coli, incubated on ice for 20 minutes and heat-
shocked for 60 seconds at 42°C. The suspension was chilled on ice, 700 μl of LB 
medium was added and incubated for 40 minutes at 37°C. The transformed bacteria 
were then plated on LB agar plates containing the appropriate antibiotic(s) and 
incubated at 37°C over night. 
 
2.2.1.4 Isolation of plasmid DNA from bacteria 
 
Plasmids were propagated in E.coli XL1-blue. Single colonies were picked from an 
agar plate and incubated in 5 ml LB medium containing the appropriate antibiotic for 
mini-preparation or 100 ml LB medium for maxi-preparation of plasmids. Plasmid 
DNA was isolated using Qiagen plasmid purification kits according to the 
manufacturer’s instructions. The DNA concentration was spectrophotometrically 
measured at 260 nm (A260) in water. An A260 value of 1 corresponds to a double-
stranded DNA concentration of 50 μg/ml. The plasmids were also visualised by a BrEt-
stained agarose gel. 
 
2.2.3 DNA techniques 
 
2.2.3.1 Polymerase Chain Reaction (PCR) 
 
Polymerase Chain Reaction was used to generate DNA fragments for cloning. A typical 
reaction contained 100 ng of template DNA, 0.4 μM of the forward and reverse 
primers, dNTPs (Roth) at a final concentration of 200 μM each, as well as 1 unit of 
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Phusion™ High Fidelity Polymerase (Finnzymes), 1x Phusion HF reaction buffer, in a 
final volume of 50 μl. PCR thermocycle protocol was as follows: initial denaturation 
for 5 minutes at 95°C, followed by 25 cycles of 20 seconds denaturation at 95°C, 20 
seconds annealing at 57-60º C (depending on primers’ Tm) and 30 seconds/kb 
extension at 72°C. A final extension was performed for 7 minutes at 72°C. Reactions 
were performed in a T3 Thermocycler (Whatman Biometra, Göttingen, Germany). 
 
2.2.3.2 DNA Extraction from Agarose Gels  
 
DNA fragments generated by PCR or by restriction digestion were purified depending 
on their sizes on 0.8% to 1.5% agarose gels. Subsequently, excised DNA fragments 
were extracted using the QIAquick Gel Extraction Kit (Qiagen) according to the 
manufacturer’s instructions. DNA was eluted from the silica-based purification column 
with 40 µl H2O and stored at -20°C.  
 
2.2.3.3 Restriction Digests 
 
Preparative digests of agarose gel-purified PCR products to generate suitable ends for 
cloning were performed at 37°C over night using 2 U of the appropriate restriction 
enzymes in a suitable restriction buffer (NEB) supplemented with 1xBSA (2 μg in a 
reaction volume of 20 μl) where required. Preparative digest of plasmid DNA was 
performed at 37°C for 3 hours with 2 μg of DNA and 1 U of each restriction enzyme in 
its corresponding buffer. Analytical digests of plasmid DNA were performed at 37°C 
for 1.5 hours with 0.5 μg of DNA and 0.5 U of the appropriate enzymes with their 
corresponding buffer. Restriction fragments were visualized by agarose gel 
electrophoresis and gel-purified as described in 2.2.3.2. 
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2.2.3.4 Ligation 
 
Restriction digested vectors and inserts (either PCR generated or excised from a 
plasmid) were ligated in a molar ratio of 1:5 with 1 U of T4 DNA Ligase (Promega) in 
1x ligase buffer (Promega). The ligation reaction was incubated for 2 hours at room 
temperature, and transformed into competent E.coli as described in 2.2.1.3. 
 
2.2.3.5 DNA Sequencing 
 
DNA sequencing was performed by the company GATC Biotech. The following 
primers were used for sequencing: 
 
Name Sequence 
SP6 CATACATTTAGGTGACACTATAG 
T7 TAATACGACATCACTATAGGGC 
T3  CTTATCATGTCTGCTCGAAGC 
 
2.2.4 RNA techniques - RNA analysis by « in vitro splicing» 
 
2.2.4.1 In vitro Transcription 
 
Radiolabeled mRNAs for in vitro splicing were obtained by in vitro transcription. One 
microgram of the linearized plasmid was transcribed with the SP6 RNA-polymerase 
(Roche) with 50 µCi [α32-P]GTP (800 mCi/mmol; NEN) for 45 minutes at 40°C in the 
presence of nucleotides (500 µM ATP, CTP, UTP and 50 µM GTP) and 1 mM DTT 
(Promega). 1 mM of cap analog was added to the reaction (Promega). After the 45 
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minutes of incubation, DNase I digestion was performed for 15 minutes at 37 °C. The 
RNA was extracted using Trizol and chloroform. 
 
2.2.4.2 In vitro Splicing 
 
SP6 transcripts were prepared as described in the respective protocol. The pre-mix 
(ingredients used for the recycling of ATP) contained 0.1μl of 270 mM MgCl2, 0.1 μl 
of 10 mM ATP, 0.4 μl of 500 mM phosphocreatine and 0.2 μl RNAsin (Promega). The 
next step was the preparation of splice mix, which included 0.88 μl of pre-mix, 5.0 μl 
of HeLa Nuclear Extract (NE), 2.0 μl of 12% PVA, 0.55μl of 400 mM Hepes buffer 
with pH 7.3 and 0.55 μl of RNAsin. To each reaction of final volume 10 μl, 1.0 μl (1μl 
= 10,000 CPM) of radiolabeled transcript was added. The samples were kept on ice at 
all times during the preparation. The samples were incubated at 30°C for 2 to 3 hours 
(depending on the transcript used). The RNA was extracted using Trizol and 
chloroform.  
 
2.2.4.3 RNase H digestion of spliced products 
 
For RNase H digestions, MINX and MINX Δintron (Δi) transcripts were incubated 
under splicing conditions (at 30oC) for 120 minutes. For this assay MINX and MINX 
Δi transcripts with a 30 nts longer first exon were used (MINX+30 and MINX Δi+30). 
Endogenous RNase H was activated by adding a cDNA oligonucleotide (1 mM) 
complementary to the -36 position to the splicing reactions and incubating them for 15 
minutes at 30oC. RNAs were extracted and analyzed as described above. The sequence 
of the cDNA oligonucleotide was 5’-GAGTGGGCGAGC-3’. The oligonucleotide 
binds from position -42 to -31. 
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2.2.5 Protein Techniques 
 
2.2.5.1 Protein extraction 
 
For the preparation of HeLa extract, 1,400,000 HeLa cells were plated in a 10 cm dish. 
The next day, each plate was transfected with 4 μg of selected plasmid and 2 μg of 
GFP. 12-16 hours later, the transfection efficiency was checked using the fluorescent 
microscope and the cells were washed twice with TBS and incubated for another day at 
37 o C. The cells were harvested in the afternoon of the following day. Each plate was 
washed once with PBS and 800 μl of PBS were used to collect the scraped cells from 
the dish. The cells were pelleted by centrifugation of 2 minutes at 1,400 rpms. The 
supernatant was discarded and the pellet was diluted in 600 μl of lysis buffer (0.5% 
Triton X100, complete protease inhibitor and 30 μg/ μl RNase A in TBS). The resulting 
samples were vortexed and placed at -80 o C overnight.  
 
2.2.5.2 Protein concentration measurement 
 
The protein concentration of extracts was determined with the protein assay supplied by 
BioRad in a spectrophotometer (BioPhotometer, Eppendorf, Hamburg, Germany) at a 
wavelength of 595 nm. The protein concentrations were calculated using a BSA 
standard curve. 
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2.2.5.3 SDS-Polyacrylamide Gel Electrophoresis 
 
Proteins were separated according to their size by analytical sodium dodecylsulfate 
polyacrylamide gel electrophoresis (SDS-PAGE) using a minigel system (BioRad). To 
this end, samples were heated with the detergent SDS and the reducing agent DTT. The 
sample passed the upper stacking gel to concentrate the proteins before entering the 
lower resolving gel. Stacking and 8-, 10- or 12% resolving gels were polymerized by 
mixing the respective solutions with 0.1% ammonium peroxodisulfate (APS) and 
0.04% (resolving gel) or 0.1% (stacking gel) N,N,N’,N’-tetramethyl-ethylendiamine 
(TEMED). Protein samples were mixed with 6x SDS sample buffer and heated for 5 
minutes at 95°C prior to loading. Electrophoresis was carried out in 1x Laemmli buffer 
at constant current of 30 mA until the desired resolution was reached as judged by the 
separation of molecular weight markers (NEB and Fermentas). Subsequently the gel 
was processed for immunoblotting. 
 
2.2.5.4 Immunoprecipitation of proteins 
 
The samples, from the protein extraction, were thawed and the insoluble material was 
pelleted by centrifuging at 10,000 rpms for 10 minutes. From the resulting supernatant, 
an aliquot of 60 μl was kept for loading control; the rest of the supernatant was used for 
immunoprecipitation. For the Flag-Immunoprecipitation, 30 μl of FLAG beads (ANTI-
FLAG M2-Agarose from mouse from Sigma) were washed with 500 μl of Lysis Buffer. 
As a next step, the 600 μl of HeLa extract was added to the agarose and the samples 
were rotated for 2 hours at 4 o C. The samples were washed three times with 900 μl of 
wash buffer (0.5% Triton X100 in TBS). After the 3rd wash, the supernatant buffer was 
removed and 800 μl of wash buffer were added to the “dry” beads. The solution of 
beads and wash buffer was transfered to the spin columns (Micro Bio-Spin 
Chromatography Columns from BIORAD). The flow-through was discarded and the 
bound protein complexes were eluted with 60 μl of 1x SDS loading buffer by 
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centrifuging 1 minute at 1,000 g. Samples were then analyzed by SDS-PAGE and 
immunoblot. 
 
2.2.5.5 Immunological Detection of Proteins on a Solid Support -
Immunoblot 
 
Immunoblot analysis was performed using 10-30 μg of extracts for 8-12% SDS-
polyacrylamide gel electrophoresis. Samples were blotted with a semidry method onto 
Westran nitrocellulose membrane (Whatman Schleicher & Schuell) pre-equilibrated in 
methanol and sandwiched together with the gel between 8 Whatmann 3MM papers 
equilibrated in either cathode or anode buffer. This sandwich (depicted in the following 
scheme, figure 9) was then mounted into a transblot semidry transfer chamber (BioRad) 
and a current (1 mA/cm2 of gel) was applied for 1-1.5 hours. The membrane was 
blocked for unspecific binding with 5% non-fat skimmed milk in TBS-Tween (0.1%) 
for 1 hour on a shaking platform. Next, the blot was incubated overnight with shaking 
at 4°C with the primary antibody diluted in TBS-T containing 5% milk. The blot was 
washed three times (20 minutes each) with TBS-T, incubated for 1 hour with 
secondary, horseradish peroxidase coupled antibody (Sigma-Aldrich) diluted in TBS-T 
containing 5% milk. Again, the blot was washed three times (45 minutes each) with an 
excess of TBS-T. Blots were developed with ECL Western Blotting Detection Reagent 
or ECL plus Western Blotting Detection Reagent (Amersham Pharmacia Biotech). The 
specific primary antibodies and secondary antibodies used in this study are listed with 
their corresponding dilutions in section 2.1.4. Signals were visualized on 
autoradiograph ECL film (Amersham Pharmacia Biotech). 
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Figure 9: Transfer assembly for Immunoblot 
 
2.2.5.6 Protein Preparation and Dialysis 
 
This protocol describes a four-day procedure. During the first day, a 5 ml LB culture 
with the necessary antibiotics was inoculated with a single bacterial colony. This small 
colony was grown overnight at 37o C with shaking. The next day, a big culture (450 
mL) with ZYM 5052 Medium, containing the appropriate antibiotics and the 5 mL 
culture was started. It was left to grow at 37o C for 4 hours shaking. Once the 4 hours 
had elapsed, the culture was transferred to an incubator of 25o C and it was left to grow 
overnight shaking. The third day, the big culture was divided into 4 aliquots. These 
aliquots were centrifuged for 15 minutes and the pellet was kept. If the pellet was pure, 
the next step was followed. In case the pellet seemed inpure, it was washed with 10 mL 
1X PBS, placed in a 50 mL falcon and centrifuged for 10 minutes. The PBS was 
discarded and 10 mL of lysis buffer (20 % General Buffer (100 mM NaCl in 1X PBS), 
0.002% Triton X 100, 0.2 mM PMSF and 0.8 mM DTT) were added to the resulting 
pellet. The samples were vortexed and incubated on ice for 30 minutes. While 
incubating on ice, the samples were vortexed from time to time. The pellets were 
+ 
_ Cathode
Anode 
Soaked in cathode 
Soaked in anode buffer  
Gel
membrane 
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sonicated for 5 minutes at settings 7/30/pulse and centrifuged for 15 minutes. The 
resulting supernatants were kept for the following steps, while the pellets were 
discarded. In the meantime, the protein purification column was prepared by adding 
1mL Glutathione Sepharose, the slurry was left to flow through by gravity. Then 1 mL 
of 1X PBS was added and the resulting solution was mixed by pipetting. The column 
was allowed to empty by gravity and this washing step was repeated once more. The 
bottom lid of the column was placed, then the column was loaded with the supernatant 
(approximately 10 ml), and at the end the top lid was used to close the column. The 
column was rotated (during this step the protein binds to the sepharose) at 4 o C for 1 
hour 30 minutes. The sepharose was washed twice with wash buffer (80% of General 
Buffer, 0.008% Triton X 100 and 0.8 mM DTT). The column was allowed to empty by 
gravity and for the elution 1 mL of glutathione buffer was added. Once the elution 
buffer was added, the column was mixed by inverting it and it was incubated for 5-10 
minutes at room temperature. The eluate was collected in an eppendorf tube; the elution 
step was repeated 5-6 times. The first 2-3 eluates are aliquots with the highest protein 
concentration. At this point, an SDS PAGE gel was used to check the protein’s 
presence and quality. Once this quality control check point was passed, the protein was 
dialysed overnight at 4 o C in the following dialysis buffer (500 mM NaCl and 5% 
glycerol diluted in 1X PBS). For the dialysis, the D-TubeTM Dialyzer Maxi, MWCO 6-8 
kDa from Novagen was used. On the last day, if an extra purification step is required, 2 
ml of Ni-NTA Agarose (Qiagen) was added to a purification column. The resin was 
washed with 3 ml of 1X PBS. The sample from 1st dialysis was added to the column 
and rotated at 4 o C for 2 hours. An aliquot of the 1st dialysis before loading sample to 
the column was kept. After 2 hours of rotation, the resin was washed with 50 ml wash 
buffer (50 mM NaH2PO4, 300 mM NaCl and 20 mM imidazole: Adjust pH value to 8.0 
using NaOH). The sample was eluted with 4 ml of elution buffer (50 mM NaH2PO4, 
300 mM NaCl and 250 mM imidazole: Adjust pH value to 8.0 using NaOH). The eluate 
was collected and dialysed overnight with the same buffer as before. On the 5th Day the 
twice-dialysed protein was obtained. 
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2.2.5.7. Coomassie Staining 
 
Disassemble the gel. Place gel in a box and cover with Coomassie stain solution. The 
coomassie stain solution includes: 40% (v/v) methanol, 10% (v/v) acetic acid and 2.5 g 
Coomasie Brilliant Blue (per liter). Place the box on a rocker and leave for 1 hour at 
room temperature. Discard staining solution and replace with destaining solution. 
Destaining solution includes 10% (v/v) methanol and 10% (v/v) acetic acid. Destaining 
lasts about 1 hour, shaking at room temperature. After destaining, cover gel with water 
and shake at room temperature till bands are clear. 
 
2.2.6 Cell culture techniques 
 
2.2.6.1 Propagation of human cell lines 
 
HeLa cells, which originate from a human cervical carcinoma, and HEK 293 deriving 
from human embryonic kidney cells were maintained in monolayer in 175 cm² tissue 
culture flasks (Sarsted, Nümbrecht, Germany) at 37°C and 5% CO2 in Dulbecco's 
modified Eagle's medium (DMEM) (Gibco BRL) supplemented with 10% fetal calf 
serum (Biochrom, Berlin, Germany), 100 U/ml penicillin and 100 µg/ml streptomycin 
(PAA laboratories, Pasching, Austria). For subculturing, the cells were washed once 
with PBS and 0.05% trypsin was added and the cells were allowed to detach. 10 ml of 
cell culture medium was added and the cells were diluted 1:4 with fresh culture medium 
every 2-3 days. For the HEK 293 cells the addition of Versene (Gibco) was required for 
the detachment of the cells from the flask. 
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2.2.6.2 Transfection of Eukaryotic Cells using the 
BBS/calciumphosphate method 
 
Cells were transfected with Flag-tagged expression plasmids using the calcium 
phosphate method. HeLa cells were seeded 24 hours before transfection at a density of 
1x106 cells per 10 cm cell culture dish in 10 ml medium. Cells were transfected with 4 
µg (HeLa cells) or 8 µg (HEK 293 cells) of Flag-protein plasmids, and 2 µg of GFP-
expression vector for visual estimation of transfection efficiency. Approximately two 
hours before transfection, the medium was changed. For each sample, the appropriate 
DNA mixture was supplemented with water to 450 µl and mixed with 55 µl of 2.5 M 
CaCl2. Five hundred microliters of 2xBBS were added, mixed by vortexing, incubated 
at room temperature for 15-20 minutes and applied drop by drop to the cells. The cells 
were incubated with the precipitate for 16-18 hours at 37°C and 3% CO2. After removal 
of the precipitate with TBS, fresh medium was added to the cells. Cells were incubated 
for additional 24 hours in 5% CO2 at 37°C, washed with PBS and harvested for 
analysis. 
 
2.2.6.3 Preparation of Whole Cell Extract (WCE) 
 
1,800,000 HEK 293T cells were plated per 10 cm dish. The next day these cells were 
transfected with 8 µg of the desired plasmid and 24 hours post-transfectionally were 
harvested and whole cell extracts were prepared. The transfected cells were washed 
three times with 10 ml of ice-cold PBS each time. The washed cells were scraped and 
resuspended in 10 ml of PBS. The cells were pelleted by centrifuging at 3,000 x g for 3 
minutes at 4 °C. The supernatant PBS was removed completely without disturbing the 
cell pellet and the resulting pellet was resuspended in 200 µl of ice-cold Buffer E (20 
mM Hepes-KCl, pH 7.9, 100 mM KCl, 0.2 mM EDTA, 10% glycerol, and 1 mM 
dithiothreitol). The resuspended cells were sonicated using an Ultrasonic processor 
Model VC130PB (Sonics & Materials Inc., Newtown, PA) at 30% continuous pulse for 
5 seconds three times with an 30 seconds incubation on ice between bursts. Then the 
MATERIALS AND METHODS 
 
 
43 
 
samples were centrifuged at 15,000 x g for 20 minutes at 4 °C. The supernatant was 
stored as whole cell extracts at -80 °C.  This protocol is an adaptation from the Kataoka 
and Dreyfuss Protocol (Kataoka et al., 2004). 
 
2.2.7 Affinity Purification 
 
2.2.7.1 GRNA Chromatography 
 
2.2.7.1.1 Production of λN peptide 
 
A small LB culture of 100 ml, containing both ampicillin and kanamycin, was 
inoculated with a colony (or a bit of the frozen culture) and was grown at 37o C 
overnight. The half of this culture (50 ml) was used to inoculate a 1 L of LB plus 
Ampicillin culture. This large culture was incubated at 37o C till the OD reached a 
concentration of approximately 0.6 (approximately 1 hour). Once the appropriate OD 
was reached, the culture was induced by adding 0.1 M IPTG and incubating for 4 hours 
at 30o C. After the induction, the culture was centrifuged at 3,500 rpm for 15 minutes. 
The pellet was resuspended in 20 ml of lysis buffer (50 mM Tris pH 8.0, 500 mM 
NaCl, 0.01% Triton X-100, 2 mM DTT and Proteinase Inhibitor (Roche)-1 tablet for 50 
ml). For the disruption of the cells, the lysate was passed through the French Press-
EmulsiFlex. The sample was pushed through the press, collected and this step was 
repeated once more. After passing the lysate through the French press, it was 
centrifuged at 10,000 rpm for 20 minutes. The resulting supernatant was bound on 3 ml 
prewashed Glutathione Sepharose beads (Sepharose 4B Amersham), by rotation for 1 
hour at 4o C. The beads were subsequently washed 3 times with 10 ml of lysis buffer 
and centrifuged at 2,000 rpms for 3 minutes. The bound protein was eluted with elution 
buffer. (25 mM Glutathione in Lysis buffer w/o NaCl). The protein was dialyzed 
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(Dialysis buffer I: 50 mM Tris p.H. 8.0, 250 mM NaCl, 0.01 TX-100, but no DTT), the 
buffer was changed 2-3 times with a minimum of 30 minutes each dialysis at 4o C. An 
aliquot of 2 ml Ni-NTA slurry was washed 3 times with dialysis buffer and the dialyzed 
protein was incubated with the Ni-NTA beads for 1 hour at 4o C. The beads were 
washed once with 30 ml of 50 mM Tris pH 8.0, 250 mM NaCl, 0.01% TX-100 and 
another time with 20 ml of 50 mM Tris pH 8.0, 250 mM NaCl without TX-100. The 
bound protein was eluted with 8 ml of 400 mM imidazole (Sigma I2399-500G, 68.08) 
in buffer w/o TX-100. The protein was dialyzed three times against 1 L of dialysis 
buffer II (50 mM Tris p.H. 7.4, 100 mM NaCl, 20% glycerol and 1 mM DTT) at 4o C. 
For all the dialysis steps, dialysis membrane spectrum 12-14 kDa from Spectra/Pore 
Spectrum Laboratories was used. The resulting protein was divided in aliquots of 1 ml 
and its concentration was measured with the Bradford method. All wash steps were 
carried out at 2,000 rcf for 5 minutes. 
 
2.2.7.1.2 GRNA Affinity Purification 
 
For the affinity purification of each sample, 30 μl of glutathione sepharose were used 
and washed 2 times with 1 ml of buffer. After centrifugation at 800 rpm for 1 minute, 
150 μl of buffer and 30 μg of λN peptide-GST were added. The samples were rotated at 
4 °C for 1 hour. The beads were washed 2 times and then 150 μl of buffer and 30 μl of 
each splicing sample were added to them. The samples were rotated at 4 °C for 1 hour 
and 30 minutes. Next, the samples were centrifuged at 800 rpm for 1 minute and the 
resulting supernatant was discarded. The beads were washed 3 times with 1 ml of 
buffer, each wash for 10 minutes rotating at 4 °C. After the last wash, the samples were 
centrifuged and the maximum possible supernatant was removed and discarded. The 
resulting beads were dissolved in 600 μl of the buffer and loaded on the purification 
column. The column should empty by gravity. After the column was emptied, another 
500 μl of buffer were placed in the column. The columns were centrifuged at 1,200 rpm 
for 10 seconds. Once all the wash buffer was removed from the column, 400 μl of 
Trizol were added to the column. The flow through was collected at an eppendorf tube. 
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At the end, RNA was extracted by adding 80 μl of Chloroform, mixing well and 
centrifuging for 10 minutes at maximal speed. The resulting upper phase (from TriZol 
extraction (200 μl) from the centrifugation was mixed with 1.0 volume isopropanol. 
The samples were left to precipitate for 2 hours or longer till overnight at –20 °C. The 
next day, the samples were centrifuged at maximal speed for 15 minutes. The 
supernatant was removed completely. After air drying the formed RNA pellet, the pellet 
was resuspended in 10µl of RNA loading buffer. Before loading the samples to a 8-
10% (depending on the size of the transcript spliced) UREA Gel, they were heated for 5 
minutes at 95oC. 
 
2.2.7.2 Flag Affinity Purification 
 
As a first step, splicing reactions of 50 μl volume were assembled. The transcript was 
spliced in a combination of HeLa nuclear extract and HEK 293 whole cell extract in a 
ratio of 1:25. The splicing was left to proceed for 2 hours. For the Flag affinity 
purification, 12 μl of Flag agarose were used for each sample. After washing the Flag 
agarose one time with 300 μl of Flag IP buffer (20 mM Hepes pH 7.9, 200 mM NaCl, 
0.2% TX100, 0.1% NP40, 0.005% deoxycholate and 2 mM MgCl2), 220 μl of Flag IP 
buffer and 30 μl of the splicing reaction were added to the beads. From the original 
splicing reaction, an aliquot of 10 μl was kept and RNA was extracted from it (serving 
as the splicing input, control for the splicing efficiency). The samples were rotated for 1 
hour and 30 minutes at 4o C. Then, the agarose was washed with 600 μl of Flag IP 
buffer for 3 times, each wash lasted for 10 minutes. After the final wash, 500 μl of 
buffer were used to resuspend the agarose and the solution was loaded to columns 
(Receiver columns 20 μm from Macherey-Nagel). The column was left to empty by 
gravity and once the initial liquid went through, another 400 μl of buffer were added to 
wash the column. After a short centrifugation of 30 seconds at 0.8 rpm, 400 μl of Trizol 
were added to the column. The flow through was kept and to that 80 μl of chloroform 
were added for RNA extraction. The samples were stored at -20oC overnight. The next 
day the samples were centrifuged at maximal speed for 15 minutes, to pellet RNA. The 
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pellet was resuspended in 10 μl of RNA loading buffer. The samples were heated at 
95oC for 5 minutes and then cooled on ice for 1-2 minutes. The samples were loaded on 
a 8-10% UREA gel (depending on the size of the transcript), to analyze the affinity 
purification outcome. The gels were dried for 2 hours and 30 minutes and then they 
were exposed on PhosporImager screens and on autoradiography films to visualize the 
results. 
 
2.2.8 Production of antibodies against Exon Junction Complex 
components 
 
2.2.8.1 Expression and Purification of Proteins-Antigens 
 
Name Tag Resistance  Product Size 
(including 
tag)  
1. pET45-MAGOH-His His amp ~ 18 kDa 
2. pET32-eIF4A3 His amp ~ 70 kDa 
3. pET45-PYM-His His amp ~ 30 kDa 
4. pGEX6P1-Upf3b300 GST amp ~ 52 kDa 
5. pGEX6P1-BTZ359 GST  amp ~ 55 kDa 
6. pGEX6P1-RNPS1 
153-245 
GST amp ~ 35 kDa 
7. pGEX6P1-Y14 GST amp ~ 50 kDa 
 
Table 2. Vectors used for protein expression. 
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The expression vectors were given to the EMBL Protein Expression and Purification 
Core Facility. The BL21(DE3) and BL21(DE3)RIL cells were transformed with vectors 
1-7. The transformed samples were plated on LB-Amp (LB Amp/Cam for RIL-cells) 
and were incubated at 37°C overnight. The next day, a small culture of 3 ml in LB-
Amp (-/+Cam) was initiated and was incubated at 37°C, shaking at 250 rpm until 
OD600 ~0.4. When the expected OD was reached, the temperature was lowered to 
18°C, the culture was induced with 0.2 mM IPTG and was grown overnight at 18°C. 
The 2 ml of each culture were harvested and resuspended in resuspension buffer 
(+lysozyme, +DNase) for His- or GST-purification. They were lysed for 3 minutes in 
sonication bath and were centrifuged for 10 minutes at 14 krpm. The supernatant was 
incubated with 10 μl of appropriate resin for 30 minutes. The resin was washed three 
times with wash buffer and the bound protein was eluted with 30 μl of 2x SDS-buffer. 
For a larger amount of protein, 25 ml of LB with antibiotic were inoculated and 
were incubated overnight at 37°C shaking at 250 rpm. A large culture of 2 L LB with 
appropriate antibiotic was inoculate at 1:100 with pre-culture and was incubated at 
37°C shaking at 180 rpm until OD600 ~ 0.4-0.6. When the expected OD was reached, 
the temperature was lowered to 18°C. The culture was induced with 0.2 mM IPTG and 
was incubated overnight at 18°C. The cells were harvested and stored at -20°C. 
 
Purification of His6-tagged proteins #1-#3 
 
The pellets were resuspended on ice with lysis buffer (50 mM Tris/HCl, pH 8, 500 mM 
NaCl, 20 mM imidazole+ Roche complete inhibitor), and were disrupted in the cold 
room with two passes through the French Press. The samples were centrifuged for 45 
minutes at 45 krpm, 4°C. The supernatant was filtered through 0.45 μm filter (pellet 
was washed and was kept at -20°C), and was loaded on equilibrated HiTrap Chelating 
HP column (Ni2+, 5ml). The loading speed was 0.3-0.5 ml/min. The column was 
washed with wash buffer (50 mM Tris/HCl, pH 8, 500 mM NaCl, 20 mM imidazole) 
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with ~4 column volumes. The bound sample was eluted in elution buffer (50 mM 
Tris/HCl, pH 8, 500 mM NaCl, 500 mM imidazole). 
 
Purification of GST-tagged proteins #4-#7 
The pellets were resuspended on ice with lysis buffer (PBS, pH 7.4 + Roche complete 
inhibitor) and were disrupted in the cold room with two passes through the French 
Press. The samples were centrifuged for 45 minutes at 45 krpm, 4°C. The supernatant 
was filtered through a 0.45 μm filter and was loaded on an equilibrated HiTrap GST-
column (5 ml). The loading speed was 0.5 ml/min. The column was washed with wash 
buffer (PBS) with ~4 column volumes and was eluted in elution buffer (PBS, pH 7.4, 
20 mM GSH). 
 
2.2.8.2 Immunisation of the animals 
 
The immunisation of the animals and the bleeding were conducted by Eurogentec S.A. 
(Liege). The custom polyclonal antibody production program was followed and two 
New Zealand white rabbits (SPF) were used per protein. 
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3. RESULTS 
 
3.1 Affinity selection of mRNPs spliced in vitro to investigate potential 
substrate specific differences in the composition of EJCs 
 
The exon junction complex (EJC) is assembled ~20-24 nucleotides upstream of splice 
junctions in a splicing-dependent, but sequence-independent manner (Le Hir et al., 
2000). Little is known about what dictates the composition of the EJC. Trying to 
elucidate what influences the composition of the EJC, our hypothesis was that the 
intron downstream of the assembled EJC could influence its composition. Gehring and 
colleagues tested whether all EJC components share the same NMD cofactor 
requirements. To address this question they performed tethering assays (tethering of the 
EJC proteins Y14, MAGOH, UPF3b, RNPS1, or eIF4A3) together with siRNA-
mediated depletion of UPF1, UPF2, or Barentsz. Their data suggested that the EJC 
components Y14, MAGOH, and eIF4A3 can activate NMD in an UPF2-independent 
manner, while RNPS1-induced NMD requires UPF2. The EJC proteins Y14 and 
MAGOH depend on Barentsz and eIF4A3 for activation of NMD, whereas RNPS1 
does not. Therefore two branches were suggested: the RNPS1/UPF2-dependent and the 
Barentsz-dependent branch. The question I wanted to address was whether this 
heterogeneity of NMD-activating mRNPs is reflected into EJC assemblies.  
To address this question, the efficient splicing of different NMD substrates and 
the specific and sensitive detection of EJC components are required. Exon junction 
complexes can be assembled on suitable mRNA substrates by performing in vitro 
splicing reactions (see section 3.2). The resulting mRNP consists of the spliced mRNA, 
the EJC and additional RNA-binding proteins. The goal was to affinity purify these 
potentially differential mRNPs and compare their protein composition, focusing on the 
EJC.  
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The first step of the experimental strategy involved in vitro splicing of the 
substrates (MINX and β-globin). A number of optimization steps were required for the 
establishment of optimal splicing conditions for the substrates.  
 
3.1.1 Establishment of efficient in vitro splicing conditions 
 
In vitro splicing represents a key technique required for the experiments described in 
this thesis. The first experimental goal was to optimize the splicing efficiency of the 
substrates. 
One of the transcripts selected as a substrate for in vitro splicing was MINX. 
This transcript is derived from the human adenovirus late transcription unit and was 
used to set up the optimal in vitro splicing conditions presented in this thesis. It was 
chosen for the following reasons: 1) it has been shown that it is efficiently spliced in 
vitro (Bell et al., 2002; Merz et al., 2007) and 2) its intron activates NMD in vivo when 
introduced into a mRNA at an appropriate position (Thermann et al., 1998).  
To establish the optimal conditions for the in vitro splicing of the MINX 
transcript, the following conditions from the literature served as a starting point; a total 
reaction volume of 10 μl containing 6 μl of nuclear extract, 2 μl of 12% (w/v) polyvinyl 
alcohol, 2.4 mM of MgCl2, 0.5 mM of ATP and 20 mM of phosphocreatine was 
incubated for 90 minutes at 30oC (Tarn et al., 1994). Hepes buffer (220 mM) was added 
in the splicing reaction (Krainer et al., 1984). 
The most important components for an in vitro splicing reaction are: an optimal 
volume of splicing-competent extract, an optimized ionic strength and the reaction 
incubation time. The reaction was optimized by systematically varying the 
concentrations of one reaction component, while holding the concentration of the 
remaining components constant. The titrations included different Hepes (220 mM) pH 
values ranging from 7.0 to 7.9, MgCl2 concentrations ranging from 0.675 mM to 5.4 
mM and phosphocreatine concentrations ranging from 10 mM to 40 mM (Figure 10). 
When the optimal buffer conditions were found (Figure 10: A lane 3, B lane 3, C lane 
4), the amount of extract used in the splicing reaction and the incubation time 
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parameters were tested. With time, more and more spliced product is accumulated, thus 
incubation times ranging from 30 to 300 minutes were tested. It was observed that 
MINX was spliced up to 85% after 120 minutes (Figure 11 A, lane 4). 30% of the 
transcript input has already been spliced after 30 minutes of incubation at 30oC (Figure 
11 A, lane 2). A number of titration experiments were performed to reach the maximum 
splicing efficiency of this transcript, which reached 90%. This percentage refers to the 
amount of transcript input converted into spliced product at a given time.  
Figure 12 shows that a single reaction ingredient can influence the splicing 
efficiency of MINX. Splicing reactions were performed using the optimal buffer, 
incubation time and amount of extract conditions. At each panel, one reaction 
ingredient (stated in the triangle) is varied (Figure 12). 
 
 
 
 
Figure 10. Optimization of buffer conditions for in vitro splicing. The figure depicts a set of 
optimization experiments. The experiments shown in this figure were performed using reaction 
conditions stated in the literature, and the only parameter varied was the component that was 
tested (stated in the triangle). (A) Splicing reactions were performed in a range of Hepes buffer  
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(220 mM) pH values: 7.0-7.3-7.5-7.7 and 7.9. The optimal Hepes buffer pH value was 7.3 (lane 
3). (B) Splicing reactions were performed with increasing phosphocreatine concentrations: 10 
mM-20 mM-30 mM and 40 mM. The optimal phosphocreatine concentration was 20 mM (lane 
3). (C) Splicing reactions were performed with increasing concentrations of MgCl2: 0. 675 
mM-1.35 mM- 2.7 mM and 5.4 mM. The optimal MgCl2 concentration was 2.7 mM (lane 4). 
 
 
 
 
 
 
 
Figure 11. MINX is efficiently spliced after 120 minutes of incubation in nuclear extract. 
Transcript inputs (A and B, lane 1) and different reaction conditions tested (A, lanes 2-4 and B, 
lanes 2-5) are depicted. (A) Splicing reactions were incubated at 30 oC for 30, 60 and 120 
minutes (lanes 2-4 respectively). (B) Splicing reactions were performed in 2.5 μl- 5 μl - 7.5 μl 
and 10 μl of HeLa nuclear extract (lanes 2-5 respectively) for 120 minutes. 
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Figure 12. A single ingredient can influence the in vitro splicing efficiency of MINX. 
Radiolabeled MINX transcript is spliced in vitro under different reaction conditions. Each 
buffer component was tested using the optimal reaction conditions described in figure 10 and 
11, with one additional variable (Hepes buffer pH value, MgCl2 concentration or PC 
concentration). (A) Splicing reactions were performed in a range of Hepes buffer (220 mM) pH 
values from 7.0 to 7.9 (7.0-7.3-7.5-7.7 and 7.9). The optimal Hepes buffer pH value was 7.3 
(lane 3). (B) Splicing reactions were performed in increasing concentrations of 
phosphocreatine: 10 mM-20 mM-30 mM and 40 mM. The optimal phosphocreatine 
concentration was 20 mM (lane 3). (C) Splicing reactions were performed in increasing MgCl2 
concentrations: 0. 675 mM-1.35 mM- 2.7 mM and 5.4 mM. The optimal MgCl2 concentration 
was 2.7 mM (lane 4). 
 
 
The optimal reaction conditions for splicing MINX transcript in vitro were 
found to be the following: a total reaction volume of 10 μl containing 5 μl of HeLa 
nuclear extract, 2.7 mM of MgCl2, 0.1 mM of ATP, 20 mM of phosphocreatine, 2 μl of 
12% (w/v) polyvinyl alcohol and 220 mM of Hepes buffer with a pH value of 7.3, 
which was incubated for 120 minutes at 30oC. 
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Table 3. Summary of conditions tested to achieve optimal in vitro splicing reaction 
conditions. The optimal in vitro splicing reaction conditions include: 220 mM of Hepes buffer 
with a pH value of 7.3, 20 mM of phosphocreatine, 2.7 mM of MgCl2 and 5 μl of splicing-
competent nuclear extract.  
 
 
When the optimal conditions for MINX were achieved, the splicing of the β-
globin minigene was pursued. As depicted in figure 13, efficient splicing of β-globin 
was achieved. The β-globin splicing required longer incubation at 30oC, 180 minutes, 
compared to the MINX transcript, which required 120 minutes. The human β-globin 
mRNA is one of the most studied NMD substrates (Neu-Yilik et al., 2001) and it is 
spliced in vitro (Kole et al., 1982). Table 3 summarizes the splicing reaction conditions 
tested for MINX and β-globin transcripts. 
 
 
Transcripts Minx Β-globin 
Conditions 
Incubation time: 
60, 120, 180, 240, 300 minutes 
?  ?  
MgCl2 concentration: 
0.675 mM, 1.35 mM, 2.7 mM, 5.4 mM 
?  ?  
Hepes buffer (220 mM) pH values: 
7.0, 7.3, 7.5, 7.7, 7.9 
?  ?  
Phosphocreatine concentration: 
10 mM, 20 mM, 30 mM, 40 mM 
?  ?  
Amount of extract: 
2.5 μl, 5 μl, 7.5 μl, 10 μl 
?  ?  
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Figure 13. β-globin is efficiently spliced in vitro. In lane 1 the transcript input is depicted. β-
globin transcript is spliced in vitro (lane 2). The splicing reaction was incubated at 30oC for 180 
minutes. β-globin transcript was incubated into mock splicing conditions (lane 3). Omitting 
ATP and phosphocreatine from a splicing reaction abolishes splicing. 
 
 
3.1.2 GRNA affinity selection of differentially assembled mRNPs 
spliced in vitro 
 
In order to investigate whether the composition of mRNPs varies depending on the 
RNA substrate, a method to affinity purify these differentially assembled mRNPs from 
in vitro splicing reactions was required. After reaching the optimal in vitro splicing 
conditions for the MINX transcript, the affinity purification method was selected. In 
order to analyze the protein composition of the EJC, I employed the glutathione-
sepharose RNA (GRNA) affinity chromatography that was developed by K. Czaplinski 
(Czaplinski et al., 2005). Once the optimal conditions for the affinity purification had 
been found, the protein composition of the MINX and β-globin substrates would be 
compared. The experimental strategy is shown schematically in figure 14. 
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Figure 14. Schematic representation of the experimental strategy used to affinity select 
mRNPs spliced in vitro. The radiolabeled substrate depicted on the top is subjected to in vitro 
splicing in HeLa nuclear extract. The boxB RNA tag is used to affinity purify mRNPs along 
with the proteins that they carry. As a last step the protein composition can be investigated 
using either mass spectrometry or immunoblot analysis. 
 
 
The GRNA technique relies on the insertion of a 19-nucleotide RNA sequence 
of the λ-phage, called boxB. The boxB sequence is specifically bound by its cognate 
λN-peptide (a 22 amino acid RNA-binding domain of the lambda bacteriophage 
antiterminator protein N). When this peptide is fused to glutathione-S-sepharose, the 
resulting module is referred to as λ-GST. λ-GST mediates binding of the RNA to the 
purification resin (glutathione sepharose) thus allowing affinity purification of the 
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mRNPs (figure 14, middle panel). After washing, the purified protein complexes are 
eluted either with an excess of ligand (glutathione) or by digesting the RNA with 
RNase A. Finally, the eluted proteins can be analyzed by mass spectrometry or 
immunoblot analysis. The major advantage of this system is derived from the small size 
of the peptide and its target sequence, which facilitates cloning, its use in biochemical 
experiments, and diminishes possible interference with the fused protein. 
An array of three boxB tags was inserted at the 3’end of the MINX transcript. 
The specificity of the purification procedure was controlled using a transcript without 
any boxB tag. The transcripts were transcribed and spliced in vitro in HeLa nuclear 
extract. The affinity selected mRNPs were eluted from the selection resin using 
glutathione and protein analysis followed. In order to arrive at the final conditions, I 
extensively optimized the different steps of this complex experimental procedure.  
For the initial experiments, as exemplified by the one shown in figure 15, I used 
unspliced transcripts containing the array of boxB tags, rather than their spliced 
products.  
 
 
 
 
Figure 15. GRNA chromatography specifically affinity purifies MINX pre-mRNAs with 
cognate boxB tags. (A) An affinity purification experiment performed utilizing unspliced 
transcripts is shown. Lanes 1-3 depict the transcript inputs, which each contained 1/5 of the 
amount of transcript that was loaded onto the affinity beads. Lanes 4-6 show the pull-down of 
the transcripts. From this statement, the pull-down efficiency is estimated to be about 25%. 
Lanes 2-3 and 5-6 are duplicates of the input and the pull-down of the tagged transcript 
respectively. (B) One of the setting-up experiments is shown. Increasing amounts of affinity 
resin-beads were tested. Lanes 1 and 2 show the MINX and the MINX carrying an array of 
boxB tags transcript inputs respectively. Lanes 1, 3, 5, 7 and 9 refer to the MINX transcript and 
lanes 2, 4, 6, 8 and 10 to the tagged MINX transcript. 
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One of the initial affinity purifications of unspliced transcripts is shown in 
figure 15 A. The outcome showed a clear and specific affinity selection of the tagged 
transcript. The initial pull-down efficiency reached 25%. A transcript without any tag 
was used as a control. To improve the pull-down efficiency, several setting-up 
experiments were performed including: titrations of the amount of the affinity resin 
used, the amount of λN peptide added, incubation times of the resin with the transcripts, 
number of washing steps and washing buffers. Among the parameters tested to improve 
the pull-down efficiency was the amount of affinity resin (or as referred to in the figure, 
beads) (Figure 15 B). As shown previously in figure 15 A, the affinity selection is 
specific for the tagged transcript (Figure 15 B, lanes 4, 6, 8 and 10). Increasing amounts 
of affinity resin, 10 μl-20 μl-30 μl and 40 μl, were tested. The pull-down efficiencies 
are stated at the bottom of the figure 15 B. An amount of 10 μl of affinity resin was able 
to pull down 38% of the transcript initially loaded onto the beads. 
One of the critical parameters of the experimental system was the amount of 
initial mRNA input that was required to detect specifically bound proteins at the last 
step of purification. In vitro transcription, in the presence of radioactive element α-32P, 
did not yield high amounts of mRNA. To increase the quantity of pre-mRNA 
synthesized, the mMESSAGE mMACHINE kit, from the company Ambion, was 
employed. The high yields of pre-mRNA, resulting from use of this kit, are due to 
optimized reaction conditions for RNA synthesis in the presence of high nucleotide 
concentrations. In addition, the enzyme mix, included in the kit, contains an RNase 
inhibitor that protects the synthesized RNA from degradation. The optimal solution was 
to splice an amount of pre-mRNA synthesized using the kit, in the presence of a small 
amount of the radiolabeled transcript [10,000 cpm (counts per minute)]. To achieve the 
optimal ratio of radiolabeled and non-radiolabeled pre-mRNA, titration experiments 
were performed. In these experiments, as exemplified by the one shown in figure 16, 
increasing amounts of non-radiolabeled mRNA were added to splicing reactions where 
a small amount of radiolabeled transcript was being spliced.  
These experiments led to the discovery of the optimal reaction conditions; 
200,000 cpm of the radiolabeled transcript and 3μg of non-radiolabeled pre-mRNA 
were added to a splicing reaction, which had a total volume of 200 μl (these conditions 
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were used for the experiments shown in figures 17-19 and 21-22). The radiolabeled 
transcript was used to trace the splicing products, in order to check the splicing and the 
pull-down efficiencies, using autoradiography.  
 
 
Figure 16. Addition of non-radiolabeled transcript (up to 100 ng) in a splicing reaction 
does not decrease the splicing efficiency. Increasing amounts (ranging from 1 ng to 1μg) of 
non-radiolabeled transcript were added to splicing reactions. The total reaction volume was 10 
μl.  
 
An important parameter of this purification system is the splicing efficiency of 
the substrate used. Both the transcript and the spliced product carry the RNA affinity 
tag, which leads to the affinity selection of a mixture of those two moieties. In order to 
specifically enrich for the spliced mRNPs, the splicing efficiency must be high. Both 
MINX and tagged MINX transcripts were efficiently spliced in vitro, as shown in figure 
17 and the other figures of this section. 
Figure 17 shows an experiment validating the affinity selection of mRNPs 
carrying the boxB tag using GRNA chromatography. The specificity of the system is 
verified by the results shown in lanes 3 and 6. The spliced tagged MINX product was 
RESULTS 
 
 
60 
 
specifically precipitated (Figure 17, lane 6), while nothing was precipitated in the case 
of the untagged transcript (Figure 17, lane 3). Although multiple bands were generated 
during the splicing process of tagged MINX (Figure 17, lane 5), these bands were not 
affinity purified (Figure 17, lane 6). GRNA chromatography specifically and 
reproducibly precipitated the tagged MINX transcript. 
 
 
 
Figure 17. GRNA chromatography specifically precipitates tagged MINX spliced 
products. Transcript input (lane 1), splicing input (lane 2) and pull-down (lane 3) of the 
untagged MINX transcript are depicted. Transcript input (lane 4), splicing input (lane 5) and 
pull-down (lane 6) of the tagged MINX transcript are also shown. 
 
 
After establishing the affinity purification of mRNAs using GRNA 
chromatography (Figure 17), the next goal was to investigate the proteins bound onto 
these mRNAs (mRNPs). Two approaches were employed. The first approach 
employed, mass spectrometry, can be used for the identification of new proteins. The 
second method, immunoblot analysis, enables the detection of previously identified 
proteins, for which specific antibodies are available.  
The initial goal was to identify RNA binding proteins by mass spectrometry. 
Silver staining was performed to visualize the protein content of the affinity purified 
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mRNPs. The pull down of the spliced substrates is shown in figure 18 A. The pull-
down is specific for the mRNAs carrying the affinity tag and efficient (figure 18 A, 
lanes 3 versus 6 and 8). The protein compositions of untagged and tagged MINX 
transcripts were compared (Figure 18 B, lanes 2 and 3). MINX transcript without 
affinity tag served as the negative control for pull-down, which was performed with 
untagged MINX pre-mRNA in the presence of λN-GST. The silver staining revealed 
that the protein content of the spliced tagged MINX mRNP and the control pull-down 
had some similar protein components. The protein bands appeared more intense at the 
tagged mRNP. This result suggests that the stained proteins are not specific for the 
tagged transcript, but rather proteins that bind unspecifically to the affinity resin. 
Several approaches were employed to eliminate this unspecific protein binding. These 
approaches included increasing the salt concentration and using competitors, such as 
heparin and tRNA. In addition, different elution methods were employed, such as 
RNase A for the release of the mRNPs by cutting the unprotected RNA, TCA 
(trichloroacetic acid) protein precipitation and elution with glutathione. The elution 
with glutathione was chosen as it was shown to be a very specific and gentle elution 
method. 
In addition to the comparison of tagged and untagged spliced MINX mRNPs, 
the protein compositions of spliced and unspliced tagged MINX were compared (Figure 
18 B, lanes 3 and 4). The protein pattern of the spliced and unspliced affinity purified 
mRNPs appeared quite similar. Similarities in the protein patterns of the unspliced and 
the spliced transcript revealed that the binding of the proteins was not splicing specific. 
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Figure 18. Similar patterns of protein composition for the spliced and unspliced mRNPs. 
(A) GRNA affinity purification of untagged MINX-control (lanes 1-3) and tagged MINX (lanes 
4-8). Transcript inputs of MINX-control (lane 1) and MINX-boxBs (lane 4) are depicted. 
Splicing input (lane 2) and pull-down (lane 3) of control performed with untagged MINX pre-
mRNA in the presence of λN-GST are shown. Splicing input (lane 5) and pull-down (lane 6) of 
tagged MINX are shown. Splicing input (lane 7) and the pull-down (lane 8) of unspliced tagged 
MINX. This sample was incubated in mock splicing conditions (namely ATP and 
phosphocreatine ingredients were eliminated from the splicing mix, leading to the abrogation of 
splicing). (B) The sizes of the molecular weight marker are stated on the left side of the figure 
(lane 1). Protein composition of control pull-down (lane 2), affinity purified unspliced mRNP 
(lane 3) and affinity purified spliced mRNP (lane 4). 
 
 
The mass spectrometry analysis was performed by the EMBL proteomic core 
facility. The facility required a coomassie stained gel, like the one depicted in figure 19 
A. The pull-downs of the spliced substrates is shown in figure 19 C, the efficient and 
specific affinity selection of spliced mRNAs is the prerequisite for further protein 
analysis. The goal was to compare the protein composition of a spliced mRNP without 
any affinity tag, which served as a control pull-down (performed with untagged MINX 
pre-mRNA in the presence of λN-GST) and a tagged spliced mRNP. The staining 
revealed a similar protein pattern for both samples. The next step was to identify 
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proteins bound onto the spliced tagged mRNP, nine protein bands were chosen. These 
protein bands were very prominent at the affinity purified sample. The bands were 
selected according to their molecular weight, choosing bands close to the expected size 
of proteins of interest (known components of the EJC). These bands included: two 
bands around 34 kDa, three bands around 50 kDa and three bands around 100 kDa. In 
the group of the smaller proteins, the λN peptide was expected to be identified. Its 
identification could serve as a positive control for the mass spectrometry analysis. 
Protein eIF4A3 (47 kDa) was expected to be found in the 50 kDa group of proteins and 
among the larger proteins, UPF3b was expected to be identified. The selected bands are 
indicated by arrows in figure 19 B. 
An in-gel digestion of proteins with trypsin was used to generate peptide 
fragments. These peptide fragments were analyzed using matrix-assisted laser 
desorption/ionization mass spectrometry (MALDI/MS) to determine their exact mass. 
Resulting peptide masses were then subjected to various database searches to identify 
the protein through comparison of their masses.  
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Figure 19. The affinity purified mRNP and the control pull-down show similar protein 
patterns when visualized with coomassie staining. This figure shows the coomassie stained 
protein gel given for MS analysis. (A) Affinity purified mRNP (lane 1) and the control pull-
down performed with untagged MINX pre-mRNA in the presence of λN-GST (lane 2) are 
depicted. On the right, the molecular weight marker and the respective sizes are shown. (B) 
Magnification of lane 1 from panel (A) is shown. The bands indicated with red arrows were 
subsequently analyzed by mass spectrometry. The results are summarized in table 4. (C) 
Transcript input (lane 1), splicing input (lane 2) and pull-down (lane 3) of the control are 
shown. Transcript input (lane 4), splicing input (lane 5) and pull-down (lane 6) of affinity-
selected spliced MINX mRNPs are depicted. 
 
 
The Proteomic facility assigned the bands to specific proteins. The identified 
proteins are outlined in table 4. The MS did not identify any of the excised gel bands as 
EJC components. Some RNA binding proteins were identified such as DHX15 and 
some abundant cellular proteins such as elongation factors, heat shock proteins 90 kDa 
(Hsp90) and actin. Hsp90 is one of the most abundant proteins in eukaryotic cells, 
comprising 1–2% of cellular proteins under non-stress conditions (Sreedhar et al., 
2004). 
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As expected, two bands of low molecular weight were identified as the λN 
peptide. Summarizing these results, the specificity of this purification strategy is not 
high enough to lead to the identification of EJC components. This may be explained by 
(1) the low abundance of EJC proteins relative to other RNA binding proteins, (2) 
sample destruction by the technical procedure.  
 
Gel 
band 
excised 
Protein 
name 
Protein Description Sequence 
Coverage 
MW Peptides 
matched 
1 GST26_SCHJA Glutathione S-
transferase class-mu 26 
kDa 
50 25482 14 
2 GST26_SCHJA Glutathione S- 
transferase class-mu 26 
kDa isozyme 
39 25482 11 
3 G3P_HUMAN Glyceraldehyde-3-
phosphate 
dehydrogenase 
41 36030 11 
4 ACTB_HUMAN Actin, cytoplasmic 1 52 41710 17 
5 EF1G_HUMAN Elongation factor 1-
gamma 
32 50087 17 
6 ENOA_HUMAN Alpha-enolase - 
Homo sapiens 
46 47139 23 
7 
HS90A_HUMAN 
Heat shock protein 
HSP 90-alpha 
49 84607 34 
 
HS90B_HUMAN 
Heat shock protein 
HSP 90-beta 
41 83212 31 
 
DHX15_HUMAN 
Putative pre mRNA- 
splicing factor ATP-
dependent RNA helicase 
DHX15 - Homo sapiens 
35 90875 26 
8 EF2_HUMAN 
Elongation factor 2
27 95277 24 
9 not identified -- -- --  
 
Table 4. Mass spectrometry identifies abundant proteins, but not EJC components. The 
table summarizes the proteins identified from the excised gel bands through mass spectrometry. 
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These results demonstrated that mass spectrometry could not be used to identify 
EJC components associated with the spliced RNAs under these experimental 
conditions. The low abundance of EJC components relative to other RNA binding 
proteins is a possible explanation for this experimental difficulty. To identify the 
presence of EJC components, which are in low abundance in post-splicing mRNPs, 
immunoblot analysis was employed. This approach requires the availability of specific 
antibodies. Some antibodies (UAP56) were commercially available, while others 
(RNPS1, Y14, UPF3b) were generously donated by colleagues in the field. In order to 
obtain a complete set of antibodies, antibodies against EJC proteins (eIF4A3, Barentsz, 
MAGOH, Y14) were produced. The proteins of interest were expressed in Escherichia 
coli and subsequently purified. These proteins were used as antigens to immunize the 
rabbits used for the production of the antibodies. The antibodies were produced by the 
company Eurogentec S.A. (Liege). Due to the fact that these antibodies were not 
specific, I had to affinity purify eIF4A3 and Barentsz antibodies. A commercially 
available kit (AminoLink Plus coupling resin) was employed for the affinity 
purification. This kit is used to covalently attach proteins and other ligands to a beaded 
agarose support, which results in a stable and reusable column for affinity purification 
of antibodies, antigens and other bio-molecules. The protein used for the antibody 
production was attached to the column and then this column was used to affinity purify 
the antibody produced. In the case of eIF4A3, the affinity purification led to a highly-
specific antibody (Figure 20). In figure 20, the antibody (after the affinity purification) 
specifically immunodetected eIF4A3 protein in HeLa nuclear extract and in HEK 293 
whole cell extracts (WCEs). In addition, the antibody detected the Flag- eIF4A3 in 
HEK 293 WCEs that have been previously transfected with Flag-eIF4A3. In addition to 
these purified antibodies, commercially available antibodies (UAP56) and antibodies 
from other laboratories (UPF3b, Y14, RNPS1 and MAGOH) were used to create a 
panel of antibodies against EJC components. 
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Figure 20. Affinity selection improves the specificity of the produced α-eIF4A3. The figure 
depicts immunoblots performed using the produced eIF4A3 antibody before and after affinity 
selection using the AminoLink® Plus Immobilization Kit from Thermo Scientific/Pierce. 
 
 
Using this highly specific, affinity purified antibody, I subsequently tested 
whether the mRNPs isolated using GRNA chromatography contained eIF4A3. eIF4A3 
was the first protein investigated using immunoblot analysis, since it had been shown to 
be the platform onto which the rest of the EJC assembles (Shibuya et al., 2004). 
Therefore finding eIF4A3 co-purified with the affinity purified mRNPs gives an initial 
hint for the presence of the EJC. 
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Figure 21. GRNA Chromatography affinity purifies eIF4A3-containing mRNPs spliced in 
vitro. (A) Affinity selection of RNA products. Lanes 1-3 correspond to control pull-down 
performed with untagged MINX pre-mRNA in the presence of λN-GST. Lanes 4-6 correspond 
to the tagged MINX. Lanes 1 and 4 show transcript inputs, lanes 2 and 5 splicing inputs (of the 
sample that is consecutively loaded onto the affinity purification resin) and lanes 3 and 6 show 
each an aliquot of the affinity purified sample that is subsequently used for the immunoblot 
shown in the (B) section of this figure. (B) Immunoblot analysis of affinity purified mRNPs 
using the eIF4A3 antibody (figure 20). The control pull-down (lane 1) and the tagged MINX 
pull-down (lane 2) are shown. Protein eIF4A3 was specifically immunodetected within affinity 
purified mRNPs from the tagged MINX (lane 2). 
 
 
Protein eIF4A3 was immunodetected within affinity purified mRNPs from in 
vitro splicing reactions (Figure 21 B). The result is specific, since protein eIF4A3 was 
only detected at the affinity purified sample from the transcript with the affinity tag 
(Figure 21 B, lane 2) and not the control (Figure 21, lane 1). This outcome showed that 
the core EJC component eIF4A3 is present in the affinity purified mRNPs. 
In addition to eIF4A3, the presence of UAP56 was investigated. UAP56 was 
identified within the affinity-selected tagged MINX sample (Figure 22, lane 2). UAP56 
is an essential splicing factor needed for the U2 snRNP-branchpoint interaction 
(Fleckner et al., 1997). The stable binding of U2 snRNP at the pre-mRNA branchpoint 
is the first ATP-dependent pre-mRNA splicing process, which requires the hydrolysis 
of ATP from UAP56 (Fleckner et al., 1997).  
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To sum up the findings, eIF4A3 and UAP56 were detected within the affinity 
purified samples using immunoblot analysis. On the other hand, the proteins RNPS1, 
MAGOH, Y14 and UPF3b could not be detected. 
 
 
Figure 22. UAP56 is present within the affinity purified mRNPs. (A) Affinity selection of 
RNA products. Lanes 1-3 correspond to control pull-down and lanes 4-6 correspond to the 
tagged MINX transcript. Transcript inputs (lane 1-control and lane 4-tagged MINX) and 
splicing inputs (lane 2-control and lane 5-tagged MINX) are depicted. Pull-down inputs (lane 3-
control and lane 6-tagged MINX), namely aliquots of the affinity purified sample that was 
subsequently used for the immunoblot shown in the (B) section of this figure are depicted. (B) 
Immunoblot analysis of affinity purified mRNPs with a commercially available UAP56 
antibody. Control pull-down (lane 1) and tagged MINX pull-down (lane 2) are depicted.  
 
 
Despite optimized splicing and GRNA chromatography conditions, no EJC 
proteins were identified by mass spectrometry and the immunoblot analysis could 
detect only one EJC component, eIF4A3, and a TREX component, UAP56, but not 
other critical components of the EJC. Therefore, the experimental system was not a 
suitable method to address the question whether substrate specific differences in the 
composition of EJC exist. At this point, this approach was stopped and the attention 
was directed towards a new set of biological questions, starting with the hierarchy of 
the EJC assembly. 
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3.2 The in vitro splicing system faithfully recapitulates the splicing-
dependent deposition of EJC proteins.  
 
EJC has been assembled in vitro from recombinant proteins on a RNA substrate in the 
presence of ATP (Ballut et al., 2005). Therefore, its assembly can occur in the absence 
of the physiological deposition machinery, the spliceosome. However, under these 
experimental conditions, EJC’s physiological assembly hierarchy was not determined. 
One of the goals of this thesis was to study EJC deposition during splicing. The 
stepwise assembly of EJC during splicing, in parallel to the spliceosome assembly was 
investigated. More specifically, we tried to investigate which EJC components bind 
before exon ligation and if splicing is essential for the deposition of all the EJC core 
components (eIF4A3, MAGOH-Y14 and Barentsz) and an EJC core interacting factor, 
Upf3b. The EJC is assembled in the nucleus and it is removed from the spliced mRNA 
in the cytoplasm. A very interesting question is what mediates the EJC disassembly. 
Apart from the EJC, a number of protein complexes are assembled on the mRNA in the 
nucleus. Another protein complex that is assembled onto the mRNA in the nucleus is 
the TREX complex. Some of the TREX complex components have been suggested to 
be EJC components (Gatfield et al., 2001; Le Hir et al., 2001b; Le Hir et al., 2000). 
Therefore, I was interested to investigate the interconnection between EJC and TREX. 
One of the goals was to test whether TREX deposition is splicing and/ or EJC 
dependent. Although the splicing dependency has been addressed before (Masuda et al., 
2005), I first wanted to recapitulate the existing published results using our in vitro 
system. 
A robust experimental system was required to investigate the splicing-
dependent deposition of exon junction complex (EJC) components onto an mRNA. The 
whole cell lysate system for in vitro splicing developed in the Dreyfuss’ lab (Kataoka, 
N. and Dreyfuss, G., 2004) was employed and modified to address the questions 
described in sections 3.2-3.5. In vitro splicing reactions with the MINX pre-mRNA 
were performed in HeLa nuclear extract supplemented with splicing-competent whole 
cell extracts from HEK 293 cells expressing different FLAG-tagged EJC proteins. 
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During the splicing reaction, these tagged proteins are incorporated into the EJC and 
allow the immunoprecipitation of splicing-specific mRNPs. A schematic representation 
of the system is depicted in figure 23. 
 
 
 
 
Figure 23. Schematic representation of the in vitro splicing system. The experimental 
strategy involves the splicing of a radiolabeled (α-32P labeling is signified by the stars) 
transcript in a combination of HeLa nuclear extract and whole cell extracts prepared from HEK 
293 cells previously transfected with FLAG-tagged proteins of interest. During splicing, the 
tagged EJC protein is assembled onto the RNA. Next using the FLAG tag (red arrow), the RNA 
products are immunoprecipitated. The precipitated products can be resolved on a denaturing 
urea gel, as shown schematically. 
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From these splicing reactions, the FLAG-tagged protein is immunoprecipitated 
in association with the spliced mRNAs and other RNA binding proteins. As expected 
for EJC proteins, the spliced mRNAs specifically co-immunoprecipitated with FLAG- 
eIF4A3, -Barentsz, -MAGOH, -Y14 and -Upf3b (Figure 24 A). In order to test whether 
the immunoprecipitations are specific for spliced RNAs, a capped intronless MINX 
transcript (MINX Δi) was used. As expected, only traces of the intronless MINX 
transcript are pulled down under the same experimental conditions (Figure 24 C). As a 
positive control for the protein binding ability of the MINX Δi RNA, we have used the 
FLAG-CBP80. This protein associates with mRNAs in a splicing-independent but cap-
dependent manner. The capped intronless transcript co-immunoprecipitated with the 
FLAG-CBP80 (Figure 24 D), as expected for a capped transcript. The expression of the 
FLAG-proteins used for the immunoprecipitations is compared in figure 24 B. 
 
 
 
Figure 24. The in vitro splicing system recapitulates faithfully the splicing-dependent 
deposition of EJC proteins. (A) Splicing reactions using capped MINX substrate were 
supplemented with extracts expressing the indicated FLAG-tagged EJC proteins or unfused 
FLAG-tag as a negative control. The RNA products were precipitated through the FLAG tag 
using FLAG affinity agarose. The positions of the full length transcript and the spliced product 
are depicted schematically on the right side. (B) The expression of the FLAG-proteins used in 
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(A) is confirmed by immunoblot analysis with a FLAG antibody. (C) Splicing reactions and 
immunoprecipitations were performed as in (A) with a capped intronless MINX transcript 
(MINX Δi). (D) Splicing reactions and immunoprepcipitations with FLAG-CBP80 or unfused 
FLAG employing the intronless MINX transcript (MINX Δi) used in (C).  
 
 
Concluding, this in vitro splicing system is a valuable tool that recapitulates 
faithfully the splicing-dependent deposition of EJC proteins. This in vitro splicing 
system has been used to address questions concerning the assembly and the 
disassembly of the EJC, as described in detail in sections 3.3, 3.4, and the deposition of 
TREX complex, as described in section 3.5. Initially the hypothesis that the assembly of 
EJC is an ordered procedure with intermediate steps was tested. 
 
3.3 Ordered assembly of the Exon Junction Complex by the 
spliceosome 
 
The EJC-proteins eIF4A3, Y14 and MAGOH were found in purified spliceosomes, 
purified spliceosomal B and C-complexes, whereas Barentsz has not been identified 
among the purified proteins (Bessonov et al., 2008; Makarov et al., 2002; Makarova et 
al., 2004). These findings lead to the questions of when and in which order individual 
EJC proteins are recruited to the RNA during splicing. Our initial hypothesis was that 
the EJC components assemble on the mRNA during the formation of distinct 
spliceosomal complexes. In order to test whether the EJC assembly is stepwise, a 
comprehensive set of eIF4A3, MAGOH, and Barentsz mutants in complete or C-
complex-arrested splicing reactions was analyzed. The structure of mRNA was 
manipulated, so that the splicing process is arrested after the first step, at the stage of 
the C-complex. Arresting the spliceosome at its C form, allows the investigation of 
proteins associated before and after this step. The associated proteins can be compared 
with the proteins associated with substrates that have completed splicing.  
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3.3.1 eIF4A3 and MAGOH-Y14 form a pre-EJC before exon ligation 
 
To address the question in which order during splicing are individual EJC proteins 
recruited to the RNA, FLAG-immunoprecipitations were performed from splicing 
reactions using a MINX pre-mRNA that contained an AG?GG mutation at the 
physiological 3’ splice site. This alteration results in the blocking of the splicing 
reaction after 5’ splice site cleavage and lariat formation and before exon ligation (Reed 
et al., 1985). The products at this stage include an intron lariat-3’exon and 5’exon, plus 
the pre-mRNA that did not initiate splicing. eIF4A3, MAGOH and Y14 specifically 
precipitated the splicing intermediates (intron lariat-3’exon, 5’ exon) and the pre-
mRNA (Figure 25, lanes 8, 10 and 11). While UPF3b precipitated the pre-mRNA only 
marginally above background and did not precipitate splicing intermediates (Figure 25, 
lane 12), BTZ precipitated only some pre-mRNA (Figure 25, lane 9). This finding 
demonstrates that both, BTZ and UPF3b do not associate with the RNA at an early step 
of splicing and stable binding thus appears to occur at later stages or after splicing of 
the mRNA has been completed. This result agrees with the current view that UPF3b 
binds only to the fully assembled EJC after release of the spliceosome (Kim et al., 
2001a). The surprising finding is that BTZ does not associate with eIF4A3 during 
splicing and may even be actively excluded from the spliceosomal C-complex. The 
above finding is not expected if one takes into consideration the previously reported 
observation that BTZ can interact in vitro with eIF4A3 even in the absence of Y14 and 
MAGOH (Bono et al., 2006; Shibuya et al., 2006). 
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Figure 25. eIF4A3 and MAGOH-Y14 form a pre-EJC before exon ligation. Splicing 
reactions and immunoprecipitations were performed with a mutated MINX transcript (MINX 
GG) that does not undergo exon ligation. The unspliced transcript and the splicing 
intermediates (exon 1; lariat and exon 2) are depicted schematically. Proteins eIF4A3, MAGOH 
and Y14 precipitated both the unspliced transcript and the splicing intermediates. Proteins 
Barentsz and UPF3b precipitated only the unspliced transcript.  
 
 
These results reveal a stepwise assembly of the biochemically defined EJC core. 
The assembly reaction entails three early (eIF4A3, MAGOH, Y14) and two late 
components (BTZ and UPF3b). Interestingly, BTZ behaves in this respect like the EJC-
binding protein UPF3b. It seems that BTZ binds to eIF4A3 after the trimeric EJC core 
is fully assembled, or that binding occurs when the spliceosome has dissociated from 
the mRNA. Trying to distinguish between these two alternatives, splicing reactions 
were performed in extracts with or without the initial addition of 293 extracts 
expressing FLAG-tagged EJC proteins (Figure 26). The reactions that were performed 
without FLAG-tagged proteins were supplemented with the same amount of FLAG-
extracts after splicing was completed and further incubated on ice to allow for the 
exchange of EJC-bound factors with supplemented proteins. At the end, recombinant 
proteins and associated mRNAs were affinity purified by FLAG-immunoprecipitation. 
Specifically, eIF4A3, MAGOH and Y14 co-purified spliced mRNA when they were 
present before splicing was initiated (Figure 26, lanes 13 & 14, 17-20). This is the 
predicted result for factors that bind to the mRNA in a splicing dependent manner 
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without any exchange of components after the EJC has been assembled and splicing is 
finished. Interestingly, BTZ and UPF3b co-purified the spliced mRNA when they were 
provided before or after splicing (Figure 26, lanes 15-16 and 21-22). Thus, BTZ and 
UPF3b interact with the trimeric EJC core that is loaded on the RNA in a splicing-
dependent manner, but do not require splicing for the interaction. As shown in figure 
26, the addition of BTZ and UPF3b protein before and after splicing led in both cases to 
the incorporation of these two proteins into the EJC. This observation suggests that 
splicing itself is not required for the recruitment of neither BTZ nor UPF3b. On the 
other hand, their deposition requires the presence of other proteins such as eIF4A3, 
MAGOH and Y14. The recruitment of the latter proteins (eIF4A3, MAGOH and Y14) 
is splicing-dependent, since the addition of these proteins after splicing does not lead to 
the precipitation of spliced product. 
 
 
 
 
Figure 26. Deposition of eIF4A3, MAGOH and Y14 requires splicing, while Barentsz and 
UPF3b do not require splicing to bind at the EJC. In order to study the composition of EJC 
before and after the completion of splicing, splicing reactions were performed in the presence 
(lanes 2, 4, 6, 8, 10, 13, 15, 17, 19, 21) or absence (lanes 3, 5, 7, 9, 11, 14, 16, 18, 20, 22) of 
FLAG-protein extracts or with empty FLAG as a negative control (lanes 1 & 12). Reactions 
without added FLAG-proteins were supplemented after the completion of splicing with FLAG-
protein extracts and incubated on ice (30 minutes).  
 
 
To sum up the presented results, eIF4A3, MAGOH and Y14 assemble on the 
mRNA before exon ligation (as shown in figure 25) and they remain bound until after 
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the end of splicing (Figure 26). On the other hand, proteins BTZ and UPF3b bind only 
after exon ligation (Figure 25) and their binding is not splicing-dependent (Figure 26). 
During the course of our analyses of the splicing-mediated deposition of EJCs, 
we noticed that mutants of MAGOH designed to lack the interaction with PYM (for 
more information about PYM, see beginning of next section, section 3.4) subtly but 
reproducibly co-immunoprecipitated more spliced MINX mRNA than wild type 
MAGOH. This observation suggests that these MAGOH mutants are either more 
efficiently incorporated into EJCs, or that EJCs containing such mutants are more stable 
than EJCs with wild type MAGOH. Both effects could be caused by the lack of PYM 
interaction. The results of the analysis of these alternatives are presented in the next 
section. 
 
3.4 Disassembly of Exon Junction Complexes by PYM  
 
PYM is a 29-kDa protein that binds the Y14-MAGOH heterodimer in the cytoplasm 
(Forler et al., 2003), but does not interact with other EJC components. It has been 
proposed that PYM functions to enhance the translation of spliced mRNAs by directly 
linking the EJC to the ribosomal 48S preinitiation complex in the cytoplasm. The N-
terminus of PYM is responsible for the interaction between Y14-MAGOH and PYM 
(Bono et al., 2004), while the C-terminus is completely dispensable. The observation 
that PYM associates with the nuclear cap-binding protein CPB80 but not with the 
cytoplasmic cap-binding protein eIF4E, proposes that PYM has a role at the initial 
round of translation, rather than in steady-state translation (Chiu et al., 2004; Diem et 
al., 2007; Hosoda et al., 2005; Ishigaki et al., 2001; Lejeune et al., 2002). On the basis 
of its physical interaction with the EJC proteins and the finding that tethering of PYM 
to the 3’UTR of a reporter mRNA reduces its abundance, PYM was proposed to act as 
an NMD factor (Bono et al., 2004). Recently, PYM was shown to interact with 
ribosomes and to co-sediment with 40S ribosomal subunits in sucrose gradient 
centrifugations (Diem et al., 2007). Based on this association, PYM was proposed to 
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serve as a bridge between the EJC and the ribosome, and to mediate the stimulation of 
translation by EJCs bound within the open reading frame (Diem et al., 2007). 
 
3.4.1 PYM reduces the amount of EJCs bound to spliced mRNAs 
 
Based on the observation that MAGOH mutants lacking the interaction with PYM 
subtly but reproducibly co-immunoprecipitated more spliced MINX mRNA than wild 
type MAGOH, we hypothesized that EJCs containing such mutants are more stable 
than EJCs with wild type MAGOH. To directly test if PYM influences the EJC, we 
purified recombinant PYM (rPYM) from bacterial expression cultures and added 
increasing amounts of rPYM to splicing reactions containing FLAG-tagged EJC 
proteins. Splicing reactions containing one of the following FLAG-eIF4A3, -BTZ, -
MAGOH, -Y14 or -UPF3b were performed and then increasing amounts of rPYM were 
added, followed by FLAG-immunoprecipitations. In all cases rPYM strongly reduced 
the amount of co-precipitated MINX mRNA in a concentration dependent manner 
(Figure 27). Therefore, the effect of rPYM is specific for EJCs and independent of the 
proteins used to precipitate the EJC. Importantly, the association of CBP80 with the 
mRNA was not inhibited by PYM under the same conditions (Figure 28). Thus, PYM 
specifically targets mRNA-bound EJCs rather than non-specifically disturbing mRNPs. 
This observation suggests that PYM is one of the factors able to disassemble the EJC.  
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Figure 27. PYM reduces the amount of EJCs bound to spliced mRNAs. Splicing reactions 
in HeLa cell nuclear extract using MINX as a substrate were supplemented with 293 cell 
extracts expressing the indicated protein (eIF4A3, BTZ, MAGOH, Y14 and Upf3b) or unfused 
FLAG-tag as a negative control. Reactions were immunoprecipitated using FLAG affinity 
agarose. Increasing amounts of recombinant PYM (rPYM) were added to the reactions as 
shown.  
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Figure 28. Addition of PYM has no effect on the binding of CBP80. Splicing reactions and 
immunoprecipitations with CBP80 and Y14 were performed as described in figure 27. 
 
3.4.2 The N-terminus of PYM is required for EJC disassembly 
 
It has been shown that PYM interacts with the MAGOH-Y14 heterodimer via its N-
terminus (Bono et al., 2004). To further validate the specificity of the PYM effect on 
the EJC disassembly, a deletion mutant of PYM was generated. This mutant of PYM 
lacks the N-terminus and hence the interaction with MAGOH-Y14 should be abolished 
according to Bono et al. Splicing reactions were performed using either FLAG-eIF4A3 
or FLAG-Y14, and increasing amounts of rPYM were added to the reactions. When 
equal amounts of rPYM and rPYM ΔN33 were tested in splicing reactions, rPYM 
ΔN33 did not affect the amount of precipitated MINX mRNA (Figure 29, lanes 5-6 and 
10-11), while rPYM reproduced the usual interference (Figure 29, lanes 3-4 and 8-9). 
These results show that PYM requires its MAGOH-Y14 interacting N-terminus to 
interrupt the association of the EJC with spliced mRNA. 
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Figure 29. The N-terminus of PYM is required for EJC disassembly. Splicing reactions 
were supplemented with recombinant PYM (white triangles) or PYM ΔN33 (gray triangles). 
This PYM mutant did not disassemble the EJC. Immunoprecipitations were performed via 
eIF4A3 or Y14. 
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3.4.3 PYM dissociates assembled EJCs but does not inhibit EJC 
assembly 
 
The question of whether PYM inhibits the assembly of stable EJCs or whether it 
disrupts assembled EJCs was addressed next. Thus, we used a splicing substrate that 
completes the first step of splicing but fails to undergo exon ligation (referred to as 
MINX GG, (Reed et al., 1985) and figure 25). The EJC proteins eIF4A3, MAGOH and 
Y14 already associate with the splicing intermediate (C complex) that is formed on 
MINX GG (Figure 25). Splicing reactions were performed using FLAG-eIF4A3, 
FLAG-MAGOH and FLAG-Y14. rPYM was added to the splicing reactions, after their 
completion. Addition of rPYM does not affect the association of any of these three 
proteins with the pre-mRNA or with the C complex (Figure 30 A). Comparable 
amounts of splicing intermediates were immunoprecipitated both, in the presence and in 
the absence of rPYM (Figure 30 A). This result indicates that PYM does not interfere 
with the EJC assembly intermediate that already includes its target, MAGOH-Y14. 
Rather, EJCs become sensitive to PYM at a later step, possibly when the spliceosome 
has dissociated from the mRNA. 
If PYM is able to disassemble EJCs, it should be possible to dissociate EJCs 
from mRNAs after splicing is completed. This notion was tested by adding rPYM, or 
rPYM ΔN33 as a specificity control, to completed splicing reactions (120 minutes of 
splicing) and continued incubation for another 30 minutes. As shown in figure 30 B, the 
addition of rPYM to completed splicing reactions decreased the amount of EJCs 
associated with the spliced MINX mRNAs, whereas rPYM ΔN33 had no effect. These 
results demonstrate that PYM specifically disrupts mature EJCs, and that PYM is able 
to dissociate EJCs from spliced mRNAs. 
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Figure 30. PYM targets mature EJCs, but not spliceosome-bound EJC precursors. (A) 
Splicing reactions were performed using MINX GG as a substrate precursor RNA that does not 
undergo the second step of splicing. Immunoprecipitations were performed via eIF4A3, Y14 
and MAGOH. Reactions were supplemented with increasing amounts of recombinant PYM 
(rPYM) as indicated. (B) Splicing reactions were performed using MINX as a splicing substrate 
for 120 minutes in extracts supplemented with the indicated FLAG-proteins. After splicing was 
completed, recombinant PYM or PYM ΔN33 (gray shaded) were added and the reactions were 
incubated for another 30 minutes. Immunoprecipitations were done via eIF4A3 or Y14. 
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3.5 Deposition of the mammalian TREX complex 
 
The two previous sections (3.3 and 3.4) describe the use of the in vitro splicing system 
to address the assembly and disassembly of EJC. Now we used this system to 
investigate the deposition of other related protein complexes. The deposition of human 
TREX complex has been addressed in a number of studies. In previous work, the TREX 
members UAP56 and ALY/REF were identified as components of the exon junction 
complex (EJC) (Gatfield et al., 2001; Le Hir et al., 2001b; Le Hir et al., 2000). The EJC 
was also reported to contain the mRNA export receptor TAP/p15 (Le Hir et al., 2001b; 
Tange et al., 2004). The next step was to use the in vitro splicing system, described in 
previous sections (section 3.2), and the freshly discovered disassembly effect of PYM 
to EJCs (section 3.4), to study the deposition of the TREX complex and the EJC 
contribution to this deposition. 
The TREX (TREX TRanscription EXport) protein complex is found in all 
eukaryotes including yeast, Drosophila melanogaster and humans (Gatfield et al., 
2001; Jensen et al., 2001; Luo et al., 2001; Strasser et al., 2000, 2001; Stutz et al., 2000; 
Zhou et al., 2000). This conserved protein complex integrates steps in mRNA 
biogenesis with nuclear export. Despite its conservation, it is associated with the 
transcription apparatus in yeast and the splicing machinery in humans. The yeast TREX 
complex contains the mRNA export factors Sub2, Yra 1 and the THO complex, which 
functions in transcription elongation (Fischer et al., 2002; Jimeno et al., 2002) and 
transcription dependent recombination (Huertas et al., 2003). In yeast, this complex 
plays a role in coupling transcription to mRNA export (Abruzzi et al., 2004; Fischer et 
al., 2002; Huertas et al., 2003; Jimeno et al., 2002; Rondon et al., 2003). The human 
TREX complex is comprised of the following proteins: ALY/REF, UAP56, hTex1 and 
the hTHO complex (hTho2, hHrp1, fSAP79, fSAP35, fSAP24) (Jimeno et al., 2002; 
Masuda et al., 2005; Strasser et al., 2002). A detailed table of the TREX members in 
yeast, Drosophila melanogaster and human (table 1) is present in the introduction 
section. In human, UAP56 and ALY/REF colocalize with splicing factors in nuclear 
speckle domains and confocal microscopy studies in mammalian cells indicate that 
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UAP56 and ALY/REF are recruited to sites of active transcription in a splicing-
dependent manner (Custodio et al., 2004). The recruitment of the human TREX 
complex to spliced mRNA has reported to occur by a splicing-coupled mechanism 
rather than by the direct transcription-coupled mechanism that occurs in yeast (Masuda 
et al., 2005). 
In the literature several possible models exist concerning the deposition of the 
TREX complex. Initial studies suggested a close link between splicing and mRNA 
export in higher eukaryotes (Jimeno et al., 2002; Masuda et al., 2005; Strasser et al., 
2002). It has been proposed that ALY/REF, UAP56 and the mRNA export receptor 
TAP/p15 are recruited through the EJC (Jimeno et al., 2002; Masuda et al., 2005; 
Strasser et al., 2002). Recent studies show that hTREX is recruited in a splicing- and 
cap- dependent manner only to the 5’end of the mRNA (Jimeno et al., 2002; Masuda et 
al., 2005; Strasser et al., 2002). This recruitment requires the cap-binding subunit 
CBP80, which interacts directly with the ALY/REF subunit of the hTREX (Jimeno et 
al., 2002; Masuda et al., 2005; Strasser et al., 2002). The contribution of the EJC to the 
recruitment of TREX factors awaits an answer.  
 
3.5.1 Protein DDX39 is highly similar to protein UAP56 
 
Looking through the literature for proteins involved in the mRNA export pathway, a 
protein called DDX39 was revealed. DDX39 or URH49 is a mammalian protein that is 
highly identical to the DExH/D box protein UAP56 (Pryor et al., 2004). Saccharomyces 
cerevisiae and Drosophila melanogaster express only a single protein corresponding to 
UAP56, while human and mouse cells express both mRNAs encoding DDX39 and 
UAP56 (Pryor et al., 2004). Possibly the proteins have similar functions, since both 
proteins interact with the ALY/REF and are able to rescue the loss of Sub2p (the yeast 
homolog of UAP56) (Pryor et al., 2004). Aligning the amino acid sequences of the two 
proteins (Figure 31), the proteins are 90% identical (Figure 31 and (Pryor et al., 2004)). 
There are references concerning DDX39 in the literature, but its role has not been 
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explored before in similar assays. Therefore, it is interesting to compare the two highly 
similar proteins in terms of their function.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 31. The proteins DDX39 and UAP56 are 90% identical. Alignment of the amino acid 
sequence of these two proteins showed that they have 384/428 identical (89.72≈ 90 %) 
residues. The alignment was performed using ClustalW2. 
 
 
Having in hands a functional in vitro splicing system as well as a tool to 
specifically disassemble exon junction complexes without interfering with splicing or 
altering the structure of the mRNA, the deposition of the mammalian TREX complex 
was investigated. In particular, the following questions were addressed: is the 
DDX39    1 MAEQDVENDLLDY-DEEEEPQAPQESTPAPPKKDIKGSYVSIHSSGFRDFLLKPELLRAI 
UAP56    1 MAENDVDNELLDYEDDEVETAAGGDGAEAPAKKDVKGSYVSIHSSGFRDFLLKPELLRAI 
 
 
DDX39   60 VDCGFEHPSEVQHECIPQAILGMDVLCQAKSGMGKTAVFVLATLQQIEPVNGQVTVLVMC 
UAP56   61 VDCGFEHPSEVQHECIPQAILGMDVLCQAKSGMGKTAVFVLATLQQLEPVTGQVSVLVMC 
 
 
DDX39  120 HTRELAFQISKEYERFSKYMPSVKVSVFFGGLSIKKDEEVLKKNCPHVVVGTPGRILALV 
UAP56  121 HTRELAFQISKEYERFSKYMPNVKVAVFFGGLSIKKDEEVLKKNCPHIVVGTPGRILALA 
 
 
DDX39  180 RNRSFSLKNVKHFVLDECDKMLEQLDMRRDVQEIFRLTPHEKQCMMFSATLSKDIRPVCR 
UAP56  181 RNKSLNLKHIKHFILDECDKMLEQLDMRRDVQEIFRMTPHEKQVMMFSATLSKEIRPVCR 
 
DDX39  240 KFMQDPMEVFVDDETKLTLHGLQQYYVKLKDSEKNRKLFDLLDVLEFNQVIIFVKSVQRC 
UAP56  241 KFMQDPMEIFVDDETKLTLHGLQQYYVKLKDNEKNRKLFDLLDVLEFNQVVIFVKSVQRC 
 
DDX39  300 MALAQLLVEQNFPAIAIHRGMAQEERLSRYQQFKDFQRRILVATNLFGRGMDIERVNIVF 
UAP56  301 IALAQLLVEQNFPAIAIHRGMPQEERLSRYQQFKDFQRRILVATNLFGRGMDIERVNIAF 
 
 
DDX39  360 NYDMPEDSDTYLHRVARAGRFGTKGLAITFVSDENDAKILNDVQDRFEVNVAELPEEIDI 
UAP56  361 NYDMPEDSDTYLHRVARAGRFGTKGLAITFVSDENDAKILNDVQDRFEVNISELPDEIDI 
 
 
DDX39  420 STYIEQSR 
UAP56  421 SSYIEQTR 
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deposition of UAP56, ALY/REF and DDX39 proteins splicing-, EJC- or cap-
dependent? 
 
3.5.2 TREX complex deposition can be studied using an in vitro 
splicing system 
 
The first step was to test whether the in vitro splicing system described in section 4.2 
could be used to study TREX complex deposition. In vitro splicing reactions using the 
MINX pre-mRNA were performed in HeLa nuclear extract supplemented with splicing-
competent whole cell extracts from HEK293 cells expressing different FLAG-tagged 
TREX proteins and the EJC protein Y14 ( FLAG-Y14) as a control. During the splicing 
reaction, these tagged proteins are deposited onto the RNA and allow the 
immunoprecipitation of splicing-specific mRNPs. From these splicing reactions, 
FLAG-tagged proteins are immunoprecipitated in association with the spliced mRNAs. 
A number of factors associated with mRNA export (THOC1-7, UAP56, DDX39, NXF1 
and TAP/p15) have been tested for their ability to co-immunoprecipitate spliced mRNA 
(some of these factors are shown in figure 32).  
 
 
 
Figure 32. UAP56 specifically precipitates spliced mRNAs, while THOC5-7 associate 
neither with the pre-mRNA nor with the spliced product in a stable way. The in vitro 
splicing system (described in section 4.2) was used to test the deposition of TREX components. 
Splicing reactions in HeLa cell nuclear extract using MINX as a substrate were supplemented 
with 293 cell extracts expressing the indicated tagged protein (UAP56, NXF1 and THOC5-7) 
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or unfused FLAG-tag as a negative control. Reactions were immunoprecipitated using FLAG 
affinity agarose. 
 
 
The components of the mammalian THO complex (THOC5-7 or else called 
fSAP79, fSAP35 and fSAP24 respectively shown in figure 32 and THOC1-3 referred to 
in humans as hHrp1, hTho2 and hTex1 respectively) associated neither with the pre-
mRNA nor with the spliced product in our experimental system. This lack of 
association of these proteins hints that either these proteins are recruited in a splicing-
independent fashion [possibly earlier, since they play a role in transcription elongation 
(Fischer et al., 2002; Jimeno et al., 2002)] or that the protein region responsible for the 
interaction with the RNA is not accessible, in order to immunoprecipitate the stable 
complex under the conditions used. 
The THO complex (THOC1-3: hHrp1, hTho2 and hTex1 respectively and 
THOC5-7: fSAP79, fSAP35 and fSAP24) does not precipitate any RNA in our in vitro 
splicing experimental system, while ALY/REF, UAP56 and DDX39 were deposited 
during splicing. This shows that UAP56, DDX39 and ALY/REF assemble onto the 
RNA during splicing (Figures 32 and 33), while the THO complex possibly assembles 
at an earlier point or we cannot address its deposition under the experimental conditions 
used. The next steps address the role of splicing to the recruitment of ALY/REF, 
UAP56 and DDX39 proteins. For the rest of the thesis, these proteins UAP56, DDX39 
and ALY/REF will be referred to collectively as TREX complex (describing a 
simplified TREX complex).  
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3.5.3 TREX deposition is splicing-independent 
 
It has been reported that the deposition of the TREX complex is splicing-dependent 
(Masuda et al., 2005). In order to study the splicing-dependent deposition of TREX, a 
mutant MINX transcript lacking the intron was generated. This mutant transcript has 
been previously used in section 3.2, figure 24 C.  
Radiolabeled transcripts, intron-containing and intron-lacking, were transcribed 
in vitro. Then they were subjected to in vitro splicing in HeLa nuclear extract and HEK 
293 whole cell extracts with FLAG-tagged TREX complex components. The EJC 
protein Y14 was used as a positive control for the assay and splicing-dependent 
deposition. 
During the splicing reaction, these tagged proteins bind to specific complexes 
and allow the immunoprecipitation of splicing-specific mRNPs. If a protein binds to the 
intron-lacking substrate, binding is interpreted as being splicing-independent. 
As a first step the intron-containing transcript was analyzed. From these splicing 
reactions, the FLAG-tagged proteins (UAP56, DDX39, ALY/REF and Y14) were 
immunoprecipitated in association with the spliced mRNAs (Figure 33 A). 
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Figure 33. Deposition of the TREX complex components, UAP56, DDX39 and ALY/REF 
is splicing-independent. Splicing reactions in HeLa cell nuclear extract using MINX as a 
substrate were supplemented with HEK 293 cell extracts expressing the indicated protein 
(ALY/REF, UAP56, DDX39, Y14) or unfused FLAG-tag as a negative control. Reactions were 
immunoprecipitated using FLAG affinity agarose. (A) For the splicing reactions a MINX 
intron-containing substrate was used. (B) For the splicing reactions, a MINX intronless (MINX 
Δi) substrate was used. (C) Expression of the FLAG-proteins used in (A) and (B) is determined 
by immunoblot analysis with a FLAG antibody.  
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In order to test whether the immunoprecipitations are specific for spliced RNAs, 
we have used an intronless MINX transcript (MINX Δi). As expected, only traces of the 
intronless MINX transcript are pulled down under the same experimental conditions by 
the EJC protein Y14 (Figure 33 B). This intron-lacking transcript co-
immunoprecipitated with FLAG- ALY/REF, -UAP56 and -DDX39 (Figure 33 B). 
Figure 33 C shows an immunoblot analysis of FLAG-proteins expressed in the extracts 
used for the in vitro splicing and immunoprecipitation. The expression levels of the 
FLAG-tagged proteins are similar. 
In conclusion, splicing of MINX is not required for the deposition of UAP56, 
DDX39 and ALY/REF. This observation does not exclude a potential contribution of 
the EJC to the TREX complex deposition. The semi-quantitative nature of the assay 
does not allow the estimation of the deposition’s stoichiometry. A certain amount of the 
complex components could interact with the mRNA without the splicing-dependent 
EJC deposition, but the rest could require the presence of EJC. In order to specifically 
address the role of the EJC to the deposition of the TREX complex, two approaches 
described in the next section were followed. 
 
3.5.4 Recruitment of UAP56 and DDX39 is EJC-independent, while 
ALY/REF interacts with EJC 
 
It has been reported that in metazoans the members of the TREX complex are recruited 
to the mRNA by the EJC, or that the members of TREX constitute part of the EJC 
(Gatfield et al., 2001; Le Hir et al., 2001b; Le Hir et al., 2000). The role of the EJC to 
the deposition of TREX was addressed by two different approaches. 
The first approach makes use of a transcript with a short first exon (of only 
15nts) that cannot support the assembly of the exon junction complex (Le Hir et al., 
2001b; Merz et al., 2007). The EJC is assembled ~20-24 nucleotides upstream of an 
exon-exon junction (Le Hir et al., 2000). The spliced products of both, the intron-
containing (Figure 34 A) and intron-lacking (Figure 34 B) MINX transcripts, co-
immunoprecipitated with FLAG- ALY/REF, -UAP56 and -DDX39. As expected, 
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neither the spliced product nor the intron-lacking transcript co-immunoprecipitated with 
FLAG-Y14, confirming that the EJC is not assembled on the construct with the short 
5’exon (Figure 34 A and B, lane 5). This observation already suggests that EJC is not 
the only determinant for the recruitment of the TREX factors.  
 
 
 
Figure 34. The EJC is not crucial for the recruitment of the TREX factors. Splicing 
reactions were performed using a substrate with a short first exon that fails to assemble an EJC. 
(A) For the splicing reactions a MINX intron-containing substrate was used. (B) For the 
splicing reactions a MINX intronless substrate was used. 
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As described in section 3.4, the addition of recombinant PYM to the splicing 
reactions reproducibly and specifically dissociated assembled EJCs. This function of 
rPYM was now employed to analyze the interdependence of the TREX and the exon 
junction complexes. If the TREX components were members of the EJC or if their 
deposition was depending on the EJC, both complexes would be expected to dissociate 
once rPYM was added. This dissociation will decrease the co-immunoprecipitation of 
MINX mRNA. 
rPYM was thus added to the splicing reactions containing either FLAG- 
ALY/REF, -UAP56, -DDX39 or -Y14 and FLAG-immunoprecipitations were 
performed. As shown before, Y14 co-immunoprecipitation was limited after the 
addition of recombinant PYM in a concentration-dependent manner (Figure 35 A, lanes 
11-13). No change was observed to the amount of spliced product that was 
immunoprecipitated by UAP56 and DDX39. Therefore, the addition of rPYM has no 
effect on the deposition of these TREX components (Figure 35 A, lanes 2-10). In the 
case of ALY/REF, the association of the protein with the spliced mRNA was reduced 
significantly after the addition of rPYM (Figure 35 A, lanes 8-10). The reduction has 
been quantified, which is shown in figure 35 B. 
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Figure 35. rPYM dissociates ALY/REF significantly, but does not interfere with UAP56 
and DDX39 binding. (A) Splicing reactions were performed as described before. Reactions 
were immunoprecipitated using FLAG affinity agarose. Increasing amounts of recombinant 
PYM (rPYM) were added to the reactions as shown. (B) The graph is showing the % of RNA 
precipitated through the stated protein after the addition of increasing amounts of rPYM. The 
black asterisk indicates that the changes (for proteins ALY/REF and Y14) depicted in the graph 
are significant. A t-test was performed for the significance of the results: the p< 0.01 for 
ALY/REF and p< 0.001 for Y14. This experiment was repeated 3 times. 
 
 
The approach with the short first exon showed EJC-independent TREX 
deposition, which can be concluded from the finding that UAP56, DDX39 and 
ALY/REF precipitated both the intron-containing and the intron-lacking mRNAs. The 
absence of EJC was confirmed by the absence of its component Y14. When a more 
subtle method was used, namely the addition of rPYM, UAP56 and DDX39 did not 
show any significant change in the amount of mRNA they precipitated. ALY/REF 
showed a significant change of the amount of mRNA precipitated, which was dose-
dependent. When more rPYM was added, less mRNA was precipitated. Taken together, 
these data hint that the depositon of UAP56 and DDX39 is not directly affected by the 
EJC, while the deposition of ALY/REF seems to be. 
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3.5.5 TREX is deposited both to 5’ and 3’ends of the mRNA 
 
Cheng et al. suggested that the human export machinery is recruited to the 5’end of the 
mRNA. Its deposition was reported to be cap-dependent, binding in a region upstream 
of the EJC and only to the first exon of a transcript (Cheng et al., 2006). 
The next step was to investigate the role of the 5’end of the mRNA to the 
deposition of the TREX complex and the potential contribution of the EJC. In order to 
address these questions, an RNase H digestion approach was used. The experimental 
strategy was the following: after the completion of the splicing reaction (after 120 
minutes), a cDNA oligonucleotide complementary to position -36 of the first exon was 
added to the reaction. The addition of the complementary oligonucleotide activated the 
RNase H present in the extract which specifically cleaved the RNA substrate at position 
-36 of the first exon. This digestion generated 2 distinct fragments, the 5’end fragment 
or cap fragment and the 3’end fragment or so called EJC fragment (the position that the 
oligonucleotide binds and the cleavage products are depicted schematically in figure 
36).  
 
 
 
Figure 36. Schematic representation of the RNase H digestion assay. The cDNA 
oligonucleotide binds to position -36 (the oligonucleotide extends from position -42 to -31) of 
the 1st exon (position -36 refers to 36 nucleotides starting to count from the end of the 1st 
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exon). When the cDNA oligonucleotide is added to the splicing reaction, the endogenous 
RNase H activity digests the pre-mRNA. This digestion gives rise to two fragments: the 5’end 
that carries the cap and the 3’end fragment that carries the EJC. 
 
 
In figure 37 A, splicing reactions and FLAG immunoprecipitations without 
RNase H digestion are shown. The bottom panel (B) shows the outcome of the FLAG 
immunoprecipitations after RNase H digestion. All 3 splicing products (the fully 
spliced transcript, the cap or 5’fragment and the EJC or 3’ fragment) were 
immunoprecipitated by ALY/REF, UAP56 and DDX39. UAP56 and DDX39 exhibited 
a similar behavior, binding the cap fragment and the EJC fragment strongly (Figure 37 
B, lanes 7 and 8 respectively). ALY/REF showed a weaker binding to both fragments 
(Figure 37 B, lane 9). While Y14 co-immunoprecipitated the fully spliced product and 
the EJC fragment, but not the cap fragment (Figure 37 B, lane 10).  
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Figure 37. TREX complex proteins are deposited both to the cap-containing 5’end of the 
mRNA and the EJC-containing 3’end. (A) Splicing reactions and immunoprecipitations were 
performed as described before. UAP56, DDX39, ALY/REF and Y14 specifically precipitate the 
spliced product. (B) After splicing, RNase H digestion was performed. The resulting fragments, 
shown schematically on the side, were differentially precipitated by the tested proteins. 
 
 
 
RESULTS 
 
 
98 
 
The same experiment, as the one described above (Figure 37), was performed 
with a MINX transcript lacking an intron. Instead of the EJC protein Y14 (which does 
not bind to an intronless transcript), CBP80 was used as a control. FLAG-UAP56 and 
FLAG-DDX39 precipitated the intronless transcript strongly (Figure 38 A) (as shown 
before). FLAG-ALY/REF and FLAG-CBP80 precipitated the intronless transcript as 
well (Figure 38 A). Splicing reactions of the MINX Δi and FLAG immunoprecipitation 
with RNase H digestion are shown at the bottom panel (B) of figure 38. FLAG-UAP56 
precipitated all 3 splicing products strongly (the fully spliced transcript, the cap 
fragment and the EJC fragment). DDX39 precipitated all fragments as well, but to a 
smaller extent. ALY/REF showed a weaker binding to both fragments and the fully 
spliced transcript. CBP80 co-immunoprecipitated the fully spliced product and the cap 
fragment, but not the EJC fragment.  
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Figure 38. TREX proteins are deposited both to the 5’ and 3’ends of an intronless MINX 
transcript. (A) Splicing reactions and immunoprecipitations were performed using MINX Δi. 
UAP56, DDX39, ALY/REF and CBP80 specifically precipitated the intronless transcript. (B) 
After splicing, RNase H digestion was performed. The resulting fragments, shown 
schematically on the side, were differentially precipitated by the tested proteins. 
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In conclusion, the TREX complex proteins UAP56, DDX39 and ALY/REF are 
deposited both to 5’and 3’ends of an mRNA. This observation applies to both intron-
containing and intronless transcripts. UAP56 and DDX39 exhibited a similar behavior, 
showing a strong precipitation of the cap fragment both in the intron-containing and the 
intronless transcript. The protein ALY/REF binds strongly to the spliced mRNA, but 
very weakly to both 5’and 3’ends. The conclusion that derives from these observations 
is that for the recruitment of ALY/REF both the cap and the EJC are required or factors 
that are present both in 5’and 3’ends. In the case of the intronless transcript, proteins 
UAP56 and DDX39 assemble on both the 5’end or cap fragment and the 3’ fragment, 
while ALY/REF precipitated both fragments very weakly. It should be noted that the 
binding of ALY/REF was weaker in the case of the intronless transcript than the 
binding of the intron-containing transcript.  
 
3.5.6 Functional characterization of ALY/REF and UAP56 
 
Trying to elucidate the role of ALY/REF and UAP56 in the deposition of the TREX 
complex, several mutants were generated. The goal was to identify mutants that 
precipitate specifically either only the cap fragment or the EJC fragment. The C-
terminus of ALY/REF is required for the interaction with UAP56 (Luo et al., 2001). 
The mutants of ALY/REF generated were the following: ΔC16 is a mutant form lacking 
the C-terminal 16 amino acids, ΔC53 is a mutant form that lacks 53 C-terminal amino 
acids and mutant ΔN80 lacks 80 N-terminal amino acids. The C-terminal mutants were 
generated trying to abolish the interaction between ALY/REF and UAP56. The N-
terminal mutant would be useful to investigate the contribution of the N-terminus to the 
protein interactions. 
Three mutants of UAP56 were generated. UAP56K95N is a lysine to asparagine 
mutant at position 95 that disrupts the ATP binding site (Kota et al., 2008). The ATP 
binding site stretches from amino acid 92 to 96. The other two mutants were generated 
to lack one part of the helicase domain. Mutant ΔC171 (a fragment of the 1-256 protein 
amino acids) lacked 171 C-terminal amino acids, hence the helicase domain. A third 
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mutant lacking 251 amino acids from the N-terminus, was termed ΔN 251 (containing 
amino acids 252-427). This mutant lacked the first protein domain- DEAD box helicase 
domain. Figure 39 shows a schematic representation of the protein domains of the wild 
type proteins and the mutant forms generated. 
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Figure 39. Schematic representation of the (A) UAP56 and (B) ALY/REF wild type 
proteins and mutants studied. On the top panel of both, a graphical representation of the 
protein domains made using the MyDomains-Image Creator of ExPASy-Prosite site. The rest of 
the lanes show the different truncation mutants used for the in vitro studies. (A) Schematic 
representation of the UAP56 deletion mutants. The different domains are displayed as coloured 
geometrical shapes: the blue stands for a predicted Q motif, the Helicase ATP binding domain 
is coloured green and the Helicase C terminal domain is shown in orange. The sizes of the 
respective N- or C-deletions are indicated. (B) Schematic representation of the ALY/REF 
deletion mutants. The one RRM domain is depicted in gray. The sizes of the respective N- or C-
deletions are indicated. The abbreviation F.L. stands for full length. Q motif is a conserved 
element and it is involved in adenine recognition and in ATPase activity of DEAD-box proteins 
(Cordin et al., 2004). 
 
 
These analyses aimed at identifying mutants that show reproducible changes in 
binding to the 5’-cap or the 3’-EJC fragments. Such mutants could also represent 
valuable tools for the future analysis of the mechanisms of mRNA export. 
 
3.5.6.1 The ALY/REF residues 204-241 are required for binding to the 
cap fragment, but not to the EJC fragment. 
 
The ALY/REF mutants were tested for their ability to interact with the cap or the EJC 
fragments. Splicing reactions, as described previously, were performed and RNase H 
digestion followed. The splicing reactions were carried out in a combination of HeLa 
nuclear extract and HEK 293 whole cell extracts expressing FLAG-tagged ALY/REF 
forms, wild type and mutants (Figure 40). As described before, wild type ALY/REF 
precipitated not only the full length but also both, the 5’and 3’end fragments. The 
mutant ΔC16 showed similar precipitation pattern to the wild type (Figure 40, lane 4 
and 2 respectively) and mutant ΔN80 did not precipitate any of the resulting products 
(Figure 40, lane 5). The mutant ΔC53 displayed reduced binding of the 5’fragment, 
while the binding to the 3’fragment was comparable to that of the wild type protein 
(Figure 40, lane 3). 
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Figure 40. The ALY/REF residues 204-241 are required for binding to the cap fragment, 
but not to the EJC fragment. (A) Splicing reactions, immunoprecipitations and RNase H 
digestion were performed as described before. The resulting fragments, shown schematically on 
the side, were differentially precipitated by the tested mutants. (B) The graph is showing the % 
of RNA fragment precipitated through the mutant of ALY/REF protein. This experiment was 
repeated 3 times. (C) The diagram depicts the ALY/REF wild type and mutants in a simple 
linear form. The residues 204-241 are depicted in orange. Fl: Full Length, E: EJC fragment, C: 
cap fragment 
 
 
The generation of ALY/REF mutants led to the identification of mutant ΔC53, 
which showed a preferential binding for the EJC fragment rather than the cap fragment. 
This indicated that residues 1-204 are sufficient for the interaction with the EJC 
fragment, but not with the cap fragment. This observation shows that residues 204-257 
are important for the interaction of ALY/REF with the cap fragment. Mutant ΔC16 
showed a binding of the cap fragment comparable to the wild type. This binding is lost 
if more residues are removed from the C’-terminus. It seems that residues 204-241 are 
necessary for the interaction of ALY/REF with the cap. Mutant ΔN80 did not 
precipitate any of the fragments, indicating that residues 1-80 are crucial for these 
interactions. Further mutational analysis will help to map the protein regions involved 
at the interactions more finely.  
 
3.5.6.2 UAP56 mutants do not precipitate unspliced pre-mRNA or 
spliced mRNA fragments. 
 
Precipitations, as described at the previous section 3.5.6.1, were performed from 
splicing reactions with extracts expressing FLAG-tagged forms of UAP56 (Figure 41). 
In this case, only the wild type form of UAP56 precipitated all the products of the 
splicing and the RNase H digestion reactions. The mutants ΔC171 and ΔN175 
exhibited a similar behavior, not precipitating any of the fragments (Figure 41, lanes 7 
and 8 respectively). The data suggest that large deletions of either C’- or N’- terminus 
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of UAP56 destabilize the interaction with the mRNA. The point mutant UAP56K95N 
precipitated a reduced amount of the products, indicating that ATP binding may be 
required for the binding of this protein to the RNA. UAP56 has both RNA-stimulated 
ATP binding/hydrolysis activity and ATP-dependent RNA unwinding (Fleckner et al., 
1997; Shen et al., 2008; Shen et al., 2007), therefore a disruption at the ATP binding 
site could lead to the abrogation of its function. Disruption of the ATP domain 
abrogates the ATP-dependent binding of the UAP56 to RNA and/or changes the protein 
conformation.  
As in the case of ALY/REF, further mutational analysis may yield mutants 
lacking interactions with either the 5’ end or the 3’ end. 
 
 
 
Figure 41. UAP56 mutants do not precipitate unspliced pre-mRNA or spliced mRNA 
fragments. Splicing reactions, immunoprecipitations and RNase H digestion were performed 
as described before. The resulting fragments, shown schematically on the right side, were 
differentially precipitated by the tested mutants. Only the wild type UAP56 precipitated the 
generated fragments. Fl: Full Length, E: EJC fragment, C: cap fragment 
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In this section (3.5), the deposition of proteins UAP56, DDX39 and ALY/REF 
onto mRNAs was studied using our in vitro splicing system. It is the first time that 
DDX39, a protein 90% identical to UAP56, is used in an in vitro study and its 
deposition is directly compared to UAP56. To sum up the results of this section, the 
deposition of TREX components, UAP56, DDX39 and ALY/REF is splicing-
independent. In addition, the deposition of UAP56 and DDX39 is EJC-independent, 
while ALY/REF interacts with EJC. As a next observation, TREX is deposited both to 
5’and 3’ends of the mRNA. Through mutation analyses, the ALY/REF region, 
consisting of residues 204-241, was identified as necessary for binding to the cap 
fragment, but not to the EJC fragment (the cap and EJC fragments refer to the 
fragments generated from the RNase H digestion performed on a MINX transcript).  
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4. DISCUSSION 
 
4.1 Affinity selection of mRNPs spliced in vitro to investigate potential 
substrate specific differences in the composition of EJCs 
 
 
Gaining insight into the different steps of mRNA metabolism can be achieved by 
studying the protein composition of the respective mRNPs. The elucidation of the 
protein components requires the affinity purification of RNAs together with the 
accompanying proteins. To this end, an RNA affinity purification system was 
developed to study the mRNPs’ composition. The primary goal was to develop a 
system to affinity purify spliced mRNPs using GRNA chromatography. The ultimate 
goal was to use the established system to investigate the composition of EJCs 
assembled on different NMD substrates.  
 
4.1.1 Affinity purification of mRNPs employing GRNA 
Chromatography 
 
In this thesis, the main process under investigation is splicing. During this process, the 
protein complex of interest, the exon junction complex, is assembled onto the mRNA. 
The experimental strategy included the use of transcripts with and without RNA affinity 
tags. These transcripts are transcribed and spliced in vitro, mimicking the procedures in 
the cell that result in protein deposition. These spliced mRNPs were selected and their 
protein composition was investigated.  
RNA affinity tags have been used in the literature for similar approaches. The 
method of affinity purification employed is GRNA chromatography, a module 
developed by Kevin Czaplinski in the Mattaj laboratory (Czaplinski et al., 2005). In the 
initial experimental plan, the protein composition was to be assessed by mass 
spectrometry. This technique could have led to the potential identification of novel 
associated factors.  
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We succeeded in purifying spliced and unspliced mRNAs from HeLa nuclear 
extract, but we were not able to determine their protein composition by mass 
spectrometry. The mass spectrometry analysis did not identify EJC components within 
the affinity purified mRNPs. The protein gel bands investigated were identified as 
abundant cellular proteins. Most likely the enrichment of proteins in the affinity 
purified sample was not enough for the mass spectrometry analysis to identify the 
proteins. In addition, the background is quite high, preventing the possible 
identification of proteins under investigation. Alternatively the sample could have been 
damaged from the mass spectrometry procedure. Certain steps of the procedure could 
damage the sample, such as the generation of not properly-digested peptides, ionization 
by laser and/or the not-correct peptide mass assignment to proteins. 
The second method employed, immunoblot analysis is very sensitive and used 
to detect the presence of a previously-known protein. The necessary prerequisite is the 
existence of an antibody against the protein of interest. A specific antibody is less 
sensitive to background. The production of antibodies against proteins of interest was 
one of the taken steps. The production of antibodies against EJC components is a 
valuable tool to detect proteins in purified samples and to study protein interactions. 
Proteins eIF4A3 and UAP56 were identified within the affinity selected mRNPs. These 
results are in agreement with previously published studies (Merz et al., 2007). 
Moreover, the fact that we could not detect Barentsz is in agreement with figure 26 and 
(Gehring et al., 2009b), which show that Barentsz binds to the core EJC after splicing. 
The λN/boxB purification system adopted is based on the same principle as the 
Maltose Binding Protein (MBP)-MS2 purification system, used by other laboratories 
for the isolation of spliceosomal complexes. Using the MBP-MS2 purification system 
and mass spectrometry analyses, Makarov and colleagues have provided a list of the 
protein composition of the A, B, B* and C spliceosomal complexes (Makarov et al., 
2002). Furthermore, they have identified proteins that interact with pre-mRNA. The 
outcome of such analyses (proteins identified) can vary among different studies, 
depending on the stringency conditions and on the transcript used for the affinity 
selection. Nonetheless, our understanding of the protein composition of spliced mRNPs 
is far from complete. During the progress of this work, a study using a similar technical 
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approach, the MBP-MS2 system, was published by the Luehrmann laboratory (Merz et 
al., 2007). Merz and colleagues have identified 45 proteins studying two different 
mRNPs, one assembled on AdML mRNA and one on β-globin mRNA (Merz et al., 
2007).  
In conclusion, the GRNA chromatography approach to purify spliced mRNPs is 
a powerful tool to study the biogenesis of mRNPs. The big advantage is that the 
conditions used are close to the physiological ones. Plus, the elution with glutathione 
guaranties the smooth and total elution of the bound mRNPs. A number of experimental 
details could possibly be improved. First of all, one can notice that the transcription of 
the tagged transcript does not yield a uniform product, but rather one main product, the 
transcript at the expected size, and multiple bands of smaller size. This observation 
suggests that the transcription of this transcript is not complete. One explanation could 
be that the quality and efficiency of the RNA polymerase is compromised due to high 
GC content of the boxB regions. In order to improve the quality of the transcript used 
for in vitro splicing, one could use gel extraction of the expected product. Such a 
solution was not applicable in this case, since a combination of labeled and unlabeled 
transcripts was used. Therefore, the quality of both species could not be assessed on a 
single gel. The quality of the labeled transcript was checked on a urea gel and it did not 
look uniform. The transcription procedure in the presence of radiolabeled GTP led to 
the production of multiple RNA fragments. The quality of the unlabeled transcript was 
checked on an agarose gel. Although the resolution of agarose gel is limited, the 
unlabeled transcript looked uniform having one product at the expected product size. 
The production of shorter and incomplete products during transcription can be 
visible also later at the in vitro splicing products. One could notice that the splicing 
products of the tagged transcript include multiple bands of varying size. These 
incomplete products were not affinity purified, when GRNA chromatography was 
employed. This observation supports the previously stated incomplete transcription, 
which stops before the transcription of the 3’end where the boxBs are situated. Another 
issue is that the addition of the RNA hairpins seems to diminish the splicing efficiency 
of the transcript. This could be attributed to the fact that the size of the three boxBs is 
equal to the size of the rest of the MINX transcript itself. Another possible explanation 
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is that the boxB sequence could be inhibitory. Trying to improve the splicing 
efficiency, one could potentially overcome these issues by increasing the size of the 
exons used or by adding spacer sequences among the different boxBs. These spacer 
sequences could reduce the density of CGs in the boxB sequence. 
The absence of spliced mRNPs’ specific proteins could be attributed to the 
rather stringent purification conditions. Our initial plan was to avoid heparin or similar 
competitors and keep the experimental conditions as close to physiological as possible. 
The use of competitors was considered necessary to avoid unspecific binding. Trying to 
avoid the background, the salt concentration was increased to 500 mM, since lower 
concentrations resulted to higher backgrounds. The possibility that the use of high salt 
concentration (500 mM) and heparin (12 μg/ml) has led to the dissociation of protein 
components could not be excluded. Merz and colleagues have used a much lower salt 
concentration (150 mM) and 8 μg/ml of heparin.  
As becomes evident, the above described purification system can be used to 
address a number of biologically relevant questions, not only related to the EJC. 
Improving certain technical aspects could potentially lead to a powerful tool that can be 
used in the future to purify mRNPs for studying a number of interesting biological 
questions. 
 
4.1.2 Differentially assembled EJCs 
 
Our initial hypothesis was that different introns lead to EJCs of differential 
composition. This hypothesis was formulated based on the numerous observations that 
NMD can be activated from distinct routes. The term «distinct routes» refers to the 
protein factors that are sufficient and necessary to activate NMD. The goal was to 
splice these different substrates in vitro and using the GRNA Chromatography (section 
3.1) to assess and analyze their protein composition focusing on the EJC (s).  
The transcripts MINX and β-globin were efficiently spliced in vitro. The 
affinity selection of mRNPs seems to function properly, but the identification of protein 
components was not possible neither with mass spectrometry (as discussed above) nor 
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with immunoblot analysis. The immunoblot analysis could identify two EJC 
components, but not important others. 
It still remains undefined whether the heterogeneity of NMD-activating 
complexes is reflected into EJC assemblies or if EJC is a uniform entity. 
 
4.2 A system to study splicing-related deposition of proteins in vitro  
 
To study splicing-related deposition of proteins, we employed the simple whole cell 
lysate system for in vitro splicing. Splicing reactions were performed in a combination 
of splicing competent HeLa nuclear extracts and the HEK 293 whole cell extracts. Such 
a system has been introduced by the Dreyfuss laboratory to address the assembly of the 
EJC (Kataoka et al., 2004). We have combined our optimal in vitro splicing conditions 
with this whole cell lysate system. This modified in vitro splicing system is a very 
valuable tool to address a number of biological questions. It is a simple and easy to use 
system, making use of whole cell extracts prepared from cells transfected with tagged-
proteins of interest. Using such a system, one overcomes the need for separate 
production of recombinant proteins or the need for large amounts of protein-specific 
antibodies. A limitation of recombinant proteins is that they do not undergo post-
translational modifications as many proteins physiologically do. Moreover, this strategy 
eliminates differences that can result from different efficiencies using various 
antibodies against the EJC components; thus allowing a direct comparison among the 
EJC proteins. Certain features of this system can be modified, for instance the structure 
of mRNA in order to block splicing at specific steps or by tagging different proteins the 
direct effect of each protein can be assessed. As shown in section 3.3, a mutation of the 
splice site leads to the blocking of the splicing process after the first step. Such a 
modification allows the dissection of the splicing process, facilitating the study of 
protein composition between the two steps. Another possible manipulation, not shown 
in this thesis, is to perform splicing reactions in extracts, prepared from cells where 
certain factors have been depleted and determine the changes in the composition of 
protein complexes. 
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The system is used to answer a number of questions, as shown in the present 
thesis. Section 3.2 of the results and figure 24 shows the splicing-dependent EJC 
deposition in vitro. The RNA products can be precipitated using the FLAG tag of a 
protein. Using this purification system, the EJC formations and interactions can be 
studied and the assembly of the EJC can be assessed. This system has been used for the 
rest of the results discussed in this thesis. Sections 4.3 and 4.4 discuss results obtained 
from experiments using this system, plus additional experiments included in two 
publications. Section 4.5 reveals the ability to study the deposition of additional protein 
complexes with this in vitro splicing system. 
 
4.3 Ordered assembly of the Exon Junction Complex by the 
spliceosome 
 
The core EJC consisting of the recombinant proteins eIF4A3, BTZ, MAGOH and Y14 
self-assembles in the presence of ATP on an RNA substrate in vitro (Ballut et al., 
2005). Ballut et al. in their study do not explain how these core EJC components bind to 
RNA during the spliceosome assembly. The crystal structure of the recombinant EJC 
core (Andersen et al., 2006; Bono et al., 2006) has provided a basis for our 
experimental strategy to analyze the assembly of the EJC by the spliceosome using an 
array of EJC protein mutants. 
 
4.3.1 Definition and assembly of a minimal trimeric pre-EJC 
 
We report that the exon junction complex is assembled in an ordered and hierarchical 
way during splicing. The proposed model of the EJC assembly pathway by the 
spliceosome is depicted schematically in figure 42. The first step includes the binding 
of eIF4A3 and MAGOH-Y14 to the spliceosome before exon ligation takes place (step 
1). Taking into consideration the data presented here [for more details see (Gehring et 
al., 2009a)] and the crystal structure of the EJC core (Ballut et al., 2005; Bono et al., 
2006), we propose that the spliceosome introduces eIF4A3 to the RNA with an 
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associated change of the conformation of this protein after ATP binding (step 2). This 
conformational change facilitates the binding of MAGOH-Y14 (step 3), completing the 
assembly of the first stable EJC intermediate that we refer to as minimal pre-EJC or 
trimeric pre-EJC. The suggested assembly pathway is in agreement with a previous 
analysis of EJC assembly (Reichert et al., 2002) and the analysis of purified 
spliceosomes and spliceosomal sub-complexes, where eIF4A3, MAGOH and Y14 were 
identified in the splicing complex B, the activated spliceosome (B*) and splicing 
complex C (Bessonov et al., 2008; Makarov et al., 2002; Makarova et al., 2004). 
Our data also suggest that the trimeric pre-EJC represents the platform that 
physiologically interacts with additional EJC components. Affinity-purified spliced 
mRNPs lacking BTZ have been reported, suggesting that stable (pre-) EJCs without 
BTZ can occur under physiological conditions (Merz et al., 2007). Surprisingly, 
recombinant EJC proteins from bacteria do not interact with the spliceosome. 
Moreover, these bacterially expressed proteins appear to assemble on the RNA during 
the second step of splicing (Zhang et al., 2007). The differences observed between the 
use of bacterial proteins and recombinant proteins expressed in HEK293 cells suggest 
that posttranslational modifications of EJC proteins in mammalian cells may be 
required for the association of EJC protein(s) with the spliceosome. 
During its assembly and the different steps of splicing, the spliceosome 
undergoes a number of conformational and structural changes (Bessonov et al., 2008; 
Makarov et al., 2002). An open question that remains to be answered is how the 
suggested conformational change of eIF4A3 is achieved. The conformational change of 
eIF4A3 may be a consequence of the rearrangements that occur within the spliceosome 
when splicing proceeds. eIF4A3 is found in the activated spliceosome, so it may adopt 
the closed, RNA-bound conformation during the transition from the activated 
spliceosome to splicing complex C. The results of Gehring et al., 2009a suggest that a 
significant fraction of eIF4A3 adopts the MAGOH-Y14-bound state before exon 
ligation. It is thus likely that upon binding of ATP and MAGOH-Y14, eIF4A3 adopts a 
closed confirmation and is stably locked onto the RNA in the C-complex. 
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Figure 42. The proposed model of the EJC assembly pathway by the spliceosome.  
 
 
4.3.2 From the trimeric pre-EJC to NMD-competent core EJC 
 
One of the main interests in our laboratory is to elucidate the mechanism of NMD. The 
results presented in this part of the thesis were used as a basis for studying the 
functional implications of this assembly into the NMD activation (Gehring et al., 
2009a). As mentioned already, the EJC plays a central role in the activation of NMD in 
mammalian cells. Apart from the core EJC members, our investigation was extended to 
more peripherally associated EJC members that play a role in NMD (Gehring et al., 
2009a). Some of these EJC members, BTZ and the NMD factor UPF3b, bind to the 
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trimeric pre-EJC after the mRNA’s release from the spliceosome. BTZ is 
predominantly localized in the cytoplasm (Degot et al., 2004; Degot et al., 2002). 
Taking into consideration its localization, as well as our data that BTZ joins the trimeric 
pre-EJC after splicing (Figure 26), this interaction may occur after nuclear export of the 
mRNP. Therefore BTZ is proposed to join the EJC at a later (possibly cytosolic) step of 
assembly. Gehring et al. 2009a have shown that the interaction between the trimeric 
pre-EJC and BTZ depends on exposed surface residues of eIF4A3 including aa 
178/179. These residues also stabilize the association of eIF4A3 with spliceosomal 
complexes prior to the second step of splicing. This overlap indicates that BTZ and the 
spliceosome interact with the same region of eIF4A3. Such a finding can explain why 
nuclear BTZ fails to enter spliceosomal complexes and why BTZ has not been found in 
purified spliceosomal complexes (Bessonov et al., 2008). 
 
 
4.4 Disassembly of Exon Junction Complexes by PYM 
 
It has been proposed that the EJC is removed by ribosomes as they scan the mRNA 
during initiation and elongation (Dostie et al., 2002). PYM is identified as an active, 
ribosome-bound EJC disassembly factor in mammalian cell, using the in vitro splicing 
system. This work reveals that PYM is an EJC disassembly factor in vitro (Figure 27), 
antagonizing important EJC functions. 
 
4.4.1 PYM-mediated disassembly of mature but not maturing EJCs  
 
PYM has been crystallized as part of a heterotrimeric complex with the EJC proteins 
MAGOH-Y14 (Bono et al., 2004). Tethered PYM was reported to mediate NMD (Bono 
et al., 2004), suggesting that PYM associates with the EJC to support its functions. 
However, we noticed that the binding of EJCs to spliced mRNAs is augmented with 
mutants of MAGOH that cannot bind PYM. This observation suggested that PYM may 
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antagonize EJC assembly and/or stability, and initiated our further biochemical 
analysis. 
Remarkably, PYM does not interfere with the assembly of MAGOH-Y14 into 
EJC complexes by the spliceosome, but specifically disrupts mature EJCs after release 
of the spliceosome from the mRNA (Figure 30). This activity is mediated by direct 
protein-protein interactions between MAGOH and the N-terminus of PYM (Gehring et 
al., 2009b). The proteins eIF4A3 and PYM bind the same residues of MAGOH-Y14. 
Therefore stable binding of PYM to MAGOH-Y14 would not be possible within the 
EJC (Bono et al., 2006), suggesting that stable PYM-EJC assemblies should not exist. 
This prediction was confirmed in vitro and in vivo (Gehring et al., 2009b). This 
observation is in agreement with the results of Chamieh et al., 2008; the MAGOH-Y14 
heterodimer appears to form mutually exclusive, stable complexes with either PYM or 
within the EJC. 
These findings raise the questions of why EJC assembly intermediates including 
MAGOH-Y14 are resistant to PYM, and how PYM initiates the disassembly of mature 
EJCs. The insensitivity of maturing EJC assembly intermediates to PYM may have 
different explanations. First, spliceosomal proteins may protect MAGOH-Y14 from 
PYM during EJC assembly. This would involve interactions of MAGOH-Y14 with the 
spliceosome during the deposition of the EJC on the RNA. Second, after the release of 
the spliceosome MAGOH-Y14 heterodimers may undergo conformational changes that 
enable their interaction with PYM, or the PYM interaction may be helped by an EJC 
protein that is still lacking from the minimal EJC core after the first step of splicing. 
Based on available structural and biochemical data (Andersen et al., 2006; Bono 
et al., 2006; Bono et al., 2004; Chamieh et al., 2008; Gehring et al., 2005), we suggest 
that the interaction of PYM with solvent-accessible side chains of MAGOH-Y14 within 
the mature EJC leads to the formation of a transient intermediate that destabilizes 
MAGOH-Y14 from the EJC. As a consequence, the inhibition of the ATPase activity of 
eIF4A3 imposed by MAGOH-Y14 is removed, and ATP hydrolysis can occur since the 
ATPase active site of eIF4A3 is already positioned for catalysis (Andersen et al., 2006; 
Ballut et al., 2005; Bono et al., 2006). Once the γ-phosphate of ATP is released, it 
induces the dissociation of eIF4A3 from the mRNA (Andersen et al., 2006; Ballut et al., 
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2005; Bono et al., 2006). Moreover, eIF4A3 adopts an open conformation after ATP 
hydrolysis, preventing the re-binding of MAGOH-Y14 (Andersen et al., 2006; Bono et 
al., 2006), which is additionally avoided by the formation of trimeric PYM-MAGOH-
Y14 complexes. It will be interesting to investigate whether PYM alone is sufficient to 
disassemble EJCs that have been assembled from recombinant subunits, or whether 
PYM requires co-factors that are present in splicing extracts. Similarly, it will be 
informative to explore whether cytoplasmic proteins exist that can protect the EJC from 
disassembly by PYM. 
 
4.4.2 Functional implications of EJC disassembly by PYM for EJC 
recycling and NMD 
 
Translation and EJC removal have previously been proposed to be coupled (Dostie et 
al., 2002; Lejeune et al., 2002), but the mechanism of EJC removal has remained 
enigmatic and been attributed to the ribosomal act of translation elongation (Dostie et 
al., 2002). The results presented in section 3.4 and in Gehring et al, 2009b establish 
PYM as a ribosome-bound EJC disassembly factor. Perceiving a mammalian mRNA 
that bears premature termination codon requires the translation-dependent assessment 
of the position of the stop codon relative to the last EJC. If a messenger mRNA retains 
an EJC downstream from the stop codon, it is considered as “faulty” and it is degraded 
by NMD (Thermann et al., 1998; Zhang et al., 1998). Hence, coupling of EJC 
disassembly to mRNA translation seems logical, as it ensures (1) that EJCs are only 
removed from mRNAs that have been subjected to at least one round of translation, and 
(2) that EJCs are only removed from positions within the open reading frame but not 
from positions sufficiently far downstream of (premature) translation termination 
codons.  
These two criteria would be met if the ribosome itself was the EJC disassembly 
machine, but not if EJC disassembly is catalyzed by a soluble cytoplasmic protein that 
could remove EJCs irrespective of mRNA translation and EJC position within the 
mRNA. We propose that the tight binding of PYM to the ribosome and the lack of 
“free” cytosolic PYM serve to couple EJC removal by PYM to translation, and hence to 
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ensure proper NMD function. Indeed, accumulation of “free” cytosolic PYM inhibits 
NMD of classical NMD substrates and in tethering assays (Gehring et al., 2009b). 
The number of PYM molecules and ribosomes per cell were estimated. It was 
found that HeLa cells express far fewer molecules of PYM than the number of 
ribosomes per cell (Gehring et al., 2009b). It is interesting to discover how PYM 
associates preferentially with the ribosomes that perform (the first round of) translation, 
or how PYM-bound ribosomes are preferentially selected for translation. The way PYM 
binds to the ribosome is unknown. It may interact indirectly through the association 
with translation (initiation) factors. If this hypothesis holds true, PYM would be 
recruited only to ribosomes that are translationally active. Hence, explaining why 
overexpression of PYM leads to the accumulation of “free” cytosolic PYM despite the 
high abundance of ribosomes. Recently, PYM has been suggested to stimulate 
translation through EJCs (Diem et al., 2007); such a mechanism could help assure that 
the translation of EJC-containing mRNAs is performed by PYM-bound ribosomes. 
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Figure 43. PYM is a ribosome-bound EJC disassembly factor. Exon junction complexes are 
assembled during splicing in the nucleus. The core components of EJC, MAGOH-Y14, 
eIF4A3, BTZ are depicted in coloured shapes. BTZ most probably joins the complex at a later 
step in the cytoplasm. PYM (shown in yellow) interacts via its C-terminus (indicated by C) 
with the small ribosomal subunit and removes EJC during ribosomal passage via interaction of 
its N-terminus (N) with MAGOH-Y14. Cytosolic «free» PYM is limited by its ribosomal 
association, because it may disassemble EJCs independently of translation and thus inhibit 
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more downstream processes, such as NMD. Disassembled EJC components are recycled and 
transported back to the nucleus, with the likely exception of BTZ that may remain in the 
cytoplasm. When a premature translation termination codon (PTC) is encountered and a 
downstream EJC is recognized, NMD is activated. During the activation of NMD, UPF-
proteins bridge the EJC to the terminating ribosome. Adapted from (Gehring et al., 2009b). 
 
 
An important question is whether the number of the EJC components is enough 
to cover all the exon-exon junctions in a cell. Trying to address this issue, the number 
of exon-exon junctions within the steady-state transcriptome of HeLa cells was 
calculated to approximately 400,000 (100,000 transcripts with a mean of 4 introns; 
(Deutsch et al., 1999; Jackson et al., 1998). This number far exceeds the abundance of 
EJC subunits per cell [10,000 for eIF4A3; 40,000 for Y14 and MAGOH, respectively 
(Gehring et al., 2009b)]. This suggests that newly exported mRNAs bearing EJCs must 
be preferentially translated, and after they are translated, their EJC components should 
be efficiently disassembled and recycled. PYM may be the key factor that serves both 
needs, helping to direct translation preferentially to EJC-bound mRNAs (Diem et al., 
2007; Le Hir et al., 2003; Lu et al., 2003; Nott et al., 2004; Nott et al., 2003; Wiegand 
et al., 2003), and mediating efficient EJC disassembly and recycling. Future studies will 
address whether PYM facilitates ribosomal EJC disassembly or is required for this 
process. Future studies will also analyze the pathway(s) along which the EJC subunits 
recycle into the nucleus. 
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4.5 Deposition of the mammalian TREX complex 
4.5.1 TREX deposition is splicing-independent  
 
A number of models has been proposed for the deposition of the TREX complex. Some 
of these models suggest the involvement of EJC. Our recent discovery, that PYM 
specifically and reproducibly disassembles mature EJCs, could serve as a tool to assess 
the direct role of EJC into the mammalian TREX complex deposition. The initial goal 
was to recapitulate results in the literature which have been obtained by different 
experimental approaches. Therefore our in vitro splicing system, described earlier in 
4.2, was adapted to investigate the deposition of the mammalian TREX complex. 
Splicing reactions were performed in a combination of HeLa nuclear extracts and 293 
whole cell extracts prepared from FLAG-tagged TREX complex components. We 
initiated this study by investigating the role of splicing, EJC and cap to the mammalian 
TREX complex recruitment. This study focused on the TREX complex components 
UAP56 and ALY/REF. The investigation included protein DDX39, which is highly 
similar to UAP56 protein. The deposition of DDX39 has not been studied before in 
similar assays. The main goal was to specifically address the contribution of the EJC 
for the first time, using the addition of rPYM. These results will add valuable 
information and could lead to a more complete picture of the deposition of this 
complex. 
From the proteins tested in the in vitro system, UAP56, DDX39 and ALY/REF 
precipitated the spliced mRNAs and could be used for further studies. One of the basic 
questions in the field is whether the deposition of these factors is splicing-dependent. 
To test this question, intron-containing and intronless transcripts were used. In our 
experimental system, UAP56, DDX39 and ALY/REF are recruited both to intron-
containing and intronless transcripts. This is in agreement with a previous study, which 
has shown that proteins UAP56 and ALY/REF are recruited to an intronless transcript, 
but less efficiently than to spliced mRNA (Masuda et al., 2005). 
In order to investigate the role of EJC to TREX deposition, two approaches 
were followed. The first approach employed the use of a transcript with a short first  
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exon (of only 15 nts) that does not support the assembly of EJC and the second 
approach employed the newly found tool, the addition of rPYM to disassemble EJCs. 
Both approaches showed that UAP56 and DDX39 precipitate both, the spliced and 
unspliced mRNAs (intron-containing and intronless transcript), while the precipitation 
observed in the case of ALY/REF was less efficient than the precipitation of UAP56 
and DDX39. When rPYM was added, the amount of RNA precipitated was quantified. 
UAP56 and DDX39 did not show any significant change in the amount of mRNA they 
precipitated. On the other hand, ALY/REF showed a significant change of the amount 
of mRNA precipitated, which was dose-dependent. When more rPYM was added, less 
mRNA was precipitated. 
Previous studies have shown that UAP56 localizes to nuclear speckles (Gatfield 
et al., 2001) and that it associates with spliced mRNAs (Cheng et al., 2006; Gatfield et 
al., 2001; Masuda et al., 2005). Concerning ALY/REF, it was found to be present in 
spliced mRNP complexes, but absent from an analogous mRNP complex containing 
unspliced mRNA (Zhou et al., 2000) and spliced mRNPs-not carrying the EJC (Le Hir 
et al., 2000). In addition to these observations, ALY/REF was found to be among the 
mRNA-specific proteins associated with the 8-nucleotide-protected RNA fragment due 
to the presence of EJC (Le Hir et al., 2000). Our results suggest that ALY/REF is not a 
member of the core EJC components, but its deposition is affected by the EJC. If 
ALY/REF was a core EJC component, it would exhibit a similar behavior to eIF4A3 
and MAGOH-Y14, leading to its complete dissociation from the RNA once rPYM was 
added.  
ALY/REF does not seem to require the EJC for its interaction with the mRNA. 
It is conceivable, however, that an EJC is required for the stable association of 
ALY/REF and/ or for the proper conformational changes necessary for the ALY/REF to 
function as an export adaptor in more downstream processes, such as mRNA export. 
It has been suggested that the human TREX complex is recruited in a splicing- 
and cap-dependent manner to a region near the 5’end of the mRNA (Cheng et al., 
2006). Particularly, it was proposed that ALY/REF binds to the mRNA closest to the 
cap and THO complex, while UAP56 binds downstream of ALY/REF but upstream of 
the EJC (Cheng et al., 2006; Masuda et al., 2005). In this model, the recruitment of the 
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TREX complex to mRNA occurs via an interaction between the TREX component 
ALY/REF and the cap-binding protein CBP80. While the TREX complex is bound only 
on the first exon, the EJC is recruited at every exon-exon junction independently of the 
5’ cap/CBP80 and does not contain the mRNA export machinery (Cheng et al., 2006; 
Masuda et al., 2005). Having this information as a basis, we wanted to address the role 
of the cap-containing-5’end. The experimental approach included in vitro splicing 
followed by RNase H digestion assays. UAP56 and DDX39 precipitate strongly all 
three products (spliced product and the two RNase H digestion products: 5’and 
3’fragment), while ALY/REF precipitated the spliced product efficiently but the 5’and 
3’fragments less efficiently. A similar experiment was performed with an intronless 
transcript. UAP56 and DDX39 precipitated all three products, while ALY/REF 
precipitated all three products much less efficiently. The observation that ALY/REF 
precipitated the spliced mRNA efficiently, but the 5’and 3’fragments less efficiently 
could suggest that for the efficient and stable association of ALY/REF with the mRNA 
both the cap and the EJC are required. The observation is in accordance with previously 
published results, that TREX is recruited in a cap-dependent manner (Cheng et al., 
2006). 
 
4.5.2 Functional characterization of ALY/REF and UAP56  
 
It has been shown that ALY/REF interacts with the UAP56-C terminus as efficiently as 
with full-length UAP56, indicating that the C terminus is sufficient for ALY/REF 
binding (Masuda et al., 2005). The C terminus of ALY/REF is required not only for 
binding UAP56, but also for the hTHO complex (Masuda et al., 2005). Trying to 
acquire valuable tools for the future analysis of the mechanisms of mRNA export, 
several UAP56 and ALY/REF mutants were generated. These analyses were carried out 
aiming at the identification of mutants that show reproducible changes in binding of the 
5’or the 3’fragments. From the analyzed mutants, the UAP56K95N mutant with a 
single amino acid change at the ATP binding site precipitates very weakly the RNase  
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H-generated fragments. UAP56 mutants, having a N- or C-terminal deletion, did not 
precipitate unspliced pre-mRNA or spliced mRNA fragments. This observation hints 
that large deletions inhibit the protein’s function. This inhibition can derive from the 
fact that both the N- and C- termini are required in order for the protein to acquire its 
functional conformation. 
A yeast two-hybrid study has shown that the most frequent interaction partner 
for human UAP56 (103 of the total 117 positive clones) was either itself or a close 
paralogue (DDX39), indicating that it exists as a homo- or heterodimer (Lehner et al., 
2004). The crystal structure of human UAP56 has shown that it is composed of two 
domains connected by a flexible linker (Zhao et al., 2004). Moreover, the crystal 
structure of the N-terminal domain reveals a dimer interface that could potentially be 
important for its function (Zhao et al., 2004). From the proposed crystal structure, two 
possibilities derive. One possibility is that a dramatic conformational change is induced 
by the binding of ATP and/or substrate. This change brings the two domains closer 
together. An alternative explanation for the different domain organization is that 
UAP56, and similar DExD/H proteins, could use the different domains to fulfill distinct 
functions. The crystal structure observations support the results of our mutational 
analysis that both termini are necessary for the UAP56 protein to function properly. 
Further mutational, biochemical, and functional analyses are required to investigate the 
roles of UAP56 and DDX39 and assess the role of the dimer formation in their function 
in splicing and export. The ATPase and helicase activities of DDX39 have yet to be 
demonstrated, together with the helicase activity of UAP56.  
Testing the ability of ALY/REF mutants to precipitate spliced mRNAs and 
RNase H-digested fragments, it was observed that the deletion of 16 C- terminal amino 
acids did not affect the binding to the spliced products. In our study, the ALY/REF 
mutant ΔC16 precipitated the RNase H-generated cap fragment as efficiently as the 
wild type protein. This observation is consistent with a previous study (Cheng et al., 
2006). The ΔC16 ALY/REF mutant precipitated the cap fragment, therefore still binds 
to the cap and the cap-binding proteins like CBP80. Deletion of 80 N-terminal residues 
leads to no RNA precipitation at all. The ALY/REF mutant, lacking 53 C-terminal 
residues, shows a reduced binding of the 5’fragment, while the binding to the 3’end is 
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similar to the wild type. Taken the results from the two ALY/REF mutants (ΔC16 and 
ΔC53) together, it is evident that protein residues 204-241 play a role in the protein 
binding to the cap. Further mutational studies are required for the identification of the 
protein regions involved in the different protein interactions. 
The loading of the TREX complex seems to be directed neither solely by the 
cap nor by the EJC, but the cap seems to have a major influence. Detailed studies 
addressing the role of the cap are required to shed light on its contribution to the 
deposition of this complex. The role of the cap can be addressed, either by cap 
competition experiments or by the use of transcripts having a non-functional cap.  
As next steps, the validation of interactions between TREX members and the 
investigation of their export function is required. I would propose in order to clarify the 
export function to use Xenopus laevis oocytes system. Microinjection export assays in 
Xenopus oocyte, as described before (Hamm et al., 1990), can be performed using 
capped and uncapped transcripts, in previously depleted oocytes of certain export-
related factor, such as ALY/REF or UAP56. Depletion factors involved will help assess 
their contribution to mRNA export. 
 
4.5.3 Future directions and next steps to be taken 
 
The results presented in this thesis indicate that splicing is not necessary for the 
recruitment of ALY/REF, UAP56 and DDX39. Plus they do not provide evidence for 
the connection of UAP56 to EJC. Nonetheless, ALY/REF could be the factor that 
connects the cap and the EJC, since in our study it precipitates both the cap and EJC 
fragment. 
Current models propose that UAP56 is loaded on the mRNA first and then it 
recruits ALY/REF (Luo et al., 2001). Consecutively, ALY/REF interacts with the cap 
binding protein-CBP80. It is also possible that ALY/REF is recruited by CBP80 
(Masuda et al., 2005), but this interaction is not stable and it needs UAP56 to stabilize 
it. The ATP-dependent deposition of ALY/REF requires the hydrolysis of ATP. 
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Our model does not suggest that unspliced mRNAs are trapped into the nucleus, 
because they recruit the proteins necessary for export. It can be that export is not 
necessarily splicing-dependent, maybe splicing enhances export. Moreover, it is 
possible that the protein interaction with export receptors is splicing dependent. UAP56 
is required for the recruitment of ALY/REF to mRNA, and it is displaced from 
ALY/REF by the mRNA export factor TAP (TAP: p15) as the message is getting ready 
to be exported (Kataoka et al., 2001). It has been shown that TAP:p15 interacts with 
Y14 and MAGOH (Kataoka et al., 2001). This observation suggests a possible role for 
the EJC in recruitment of TAP: p15.  
Nojima and his colleagues suggest that ALY/REF can be deposited to an 
intronless mRNA through the cap (Nojima et al., 2007). In co-immunoprecipitation 
experiments in HEK cells, ALY/REF interacts with CBP20, and it is hypothesized that 
the recruitment of ALY/REF may play a stimulatory role to export the capped 
intronless mRNAs (Nojima et al., 2007).  
When a transcript is transcribed, the cap structure and the poly (A) tail are 
added to it, to ensure the stability of the RNA molecule. In order for a transcript to be 
capped and polyadenylated, a number of proof-reading mechanisms occur ensuring that 
the transcript has already passed the first control check point. A crucial decision in the 
process of gene expression is whether a transcript should be exported from the nucleus 
to the cytoplasm to be translated or not. At this point the cell should certify that only 
completely and correctly processed molecules are available for more downstream 
processes. Therefore some of the export factors, in this case ALY/REF, interact with 
the cap and a recently suggested possible link with the 3’end processing-Pcf11 to check 
the polyadenylation status of the transcript.  
It was recently shown that Yra 1 (the yeast homologue of ALY/REF) is 
recruited to mRNA co-transcriptionally by Pcf11 (Johnson et al., 2009). Johnson and 
colleagues show that Pcf11 and Sub2 have overlapping binding sites, suggesting that 
they bind in a mutually exclusive way (Johnson et al., 2009). The functional importance 
of Pcf11 is shown in yeast, it still remains to be determined if Pcf11 plays a role in 
mammals. These new data suggest that the recruitment of TREX components requires 
both the cap (5’end) and the 3’end. If this model holds true, factors necessary for export 
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are recruited to the RNA, only if it is correctly processed (capped and polyadenylated). 
In this way, the cell could verify the integrity of the two ends. Only if both ends are 
properly processed, the message is ready to be exported to the cytoplasm. For this 
process, namely the final decision to export or not a message, splicing is not of a 
primary importance. Hence, naturally occurring messages that have a cap and poly (A) 
tail can be physiologically exported to the cytoplasm. But splicing could play a role in 
the interaction of the export adaptor proteins with the export receptors. It is possible 
that splicing is required for the recruitment of the export adaptors, thus enhancing the 
export of the spliced products. 
One of the most appealing challenges is to understand how mRNA processing 
steps (capping, splicing and polyadenylation) can influence the downstream processes, 
starting from mRNA export. Future studies are required to find which proteins are 
recruited to the mRNPs and dictate their fates. 
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6. LIST OF ABBREVIATIONS 
 
 
A adenosine, Ampere 
A260 absorbance at 260 nm 
aa amino acid 
amp ampicillin 
APS ammonium persulfate 
ATP adenosine triphosphate 
BPS branch point sequence 
BrEt ethidium bromide 
BSA bovine serum albumin 
C. elegans Caenorhabditis elegans 
cDNA complementary DNA 
Ci Curie 
cpm counts per minute 
C-terminus carboxy-terminus 
CTP cytidine triphosphate 
dATP deoxyadenosine triphosphate 
dCTP deoxycytidine triphosphate 
dGTP deoxyguanosine triphosphate 
LIST OF ABBREVIATIONS 
 
 
137 
 
DMEM Dulbecco's modified Eagle's medium 
DMSO dimethylsulfoxide 
DNA deoxyribonucleic acid 
dNTP deoxynucleotide triphosphate 
D. melanogaster Drosophila melanogaster 
DSE downstream sequence element 
dsRNA double-stranded RNA 
dT deoxythymidine 
DTT dithiothreitol 
dTTP deoxythymidine triphosphate 
E. coli Escherichia coli 
EDTA ethylenediaminetetraacetic acid 
eIF eukaryotic translation initiation factor 
EJC exon junction complex 
eRF eukaryotic translation release factor 
ESI-MS electrospray ionization mass spectrometry 
FCS fetal calf serum 
g gram, gravitational force 
G guanosine 
GDP guanosine diphosphate 
GMP guanosine monophosphate 
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GST glutathione-S-transferase 
GT guanylytransferase 
GTP guanosine triphosphate 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
hr hour 
H2Obidest double deinonized water 
HRP horseradish peroxidase 
H. sapiens Homo sapiens 
IP6 inositol hexaphosphate 
K lysine 
kb kilobases 
kDa kiloDalton 
Km kanamycin 
L liter 
LB Luria Bertani 
μ micro 
λN N-peptide from phage λ 
M molar, methionine 
m7G 7-methyl guanosine 
mol moles 
MOPS 3-(N-morpholino)propanesulfonic acid 
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mRNA messenger RNA 
mRNP messenger ribonucleoprotein particle 
MS mass spectrometry 
MS/MALDI mass spectrometry/matrix-assisted laser desorption/ionization 
MT methyltransferase 
neo neomycin 
NE nuclear extract 
ng nanogram 
nm nanoMolar 
NMD nonsense-mediated mRNA decay 
NP40 Nonidet® P40 
NPC nuclear pore complex 
nt(s) nucleotide(s) 
N-terminus amino-terminus 
OD optical density 
ORF open reading frame 
PABP poly(A)-binding protein 
PAGE polyacrylamide gel electrophoresis 
PAS polyadenylation signal 
PBS phosphate-buffered saline 
PCR polymerase chain reaction 
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pre-mRNA precursor messenger RNA 
PTC premature termination codon 
PVA polyvinyl alcohol 
rcf relative centrifugal force 
RNase ribonuclease 
RNA ribonucleic acid 
RNAi RNA interference 
RNA Pol II RNA Polymerase II 
rpm rotations per minute 
s seconds 
S. cerevisiae Saccharomyces cerevisiae 
SDS sodium dodecyl sulphate 
siRNA small interfering RNA 
snRNPs small nuclear ribonucleoprotein particles 
SS splice site 
Taq Thermophilus aquaticus 
TBE tris/borate/EDTA 
TBS tris-buffered saline 
TEMED N,N,N',N'-tetramethylethylenediamine 
Ter termination 
Tm melting temperature 
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TREX complex trancription export complex 
Tris tris(hydroxymethyl)aminoethane 
U units, Uridine 
UPF up-frameshift protein 
uORF upstream open reading frame 
UsRNPs uridine-rich small ribonuclear particles 
UTR untranslated region 
U units 
V Volts 
v/v volume/volume 
wt wild type 
w/v weight/volume 
X. laevis Xenopus laevis 
% per cent 
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hierarchy of exon-junction complex assembly by the spliceosome explains key features 
of mammalian nonsense-mediated mRNA decay. PLoS Biol 7, e1000120. 
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Disassembly of exon junction complexes by PYM. Cell 137, 536-548. 
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